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Front: Cartoon representation of the three-dimensional structure of the chlorite dis-
mutase from the nitrifier Candidatus Nitrospira defluvii in complex with imidazole. Key
residues in the active site of the enzyme are emphasized in stick representation, as
well as the prosthetic group heme b. In this study, the reaction mechanism of chlorite
dismutases was further elucidated by mutational, biochemical and structural stud-
ies.
Contents
Contents
Zusammenfassung vii
Abstract viii
1 Introduction 1
1.1 Oxochlorates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.2 Microbial Perchlorate Respiration . . . . . . . . . . . . . . . . . . . . . . 2
1.3 Diversity of Chlorite Dismutases . . . . . . . . . . . . . . . . . . . . . . 4
1.4 Structure of Chlorite Dismutases . . . . . . . . . . . . . . . . . . . . . . 7
1.5 Active Site . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
1.6 Reaction Mechanism . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
2 Aim of this Thesis 17
3 Materials and Methods 19
3.1 Antibiotics, Media and General Buffers . . . . . . . . . . . . . . . . . . 19
3.2 Expression System and Expression Vectors . . . . . . . . . . . . . . . . 20
3.3 Storage . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
3.4 Molecular Cloning Techniques . . . . . . . . . . . . . . . . . . . . . . . 21
3.4.1 Site-Directed Mutagenesis . . . . . . . . . . . . . . . . . . . . . . 22
3.4.2 Chemical Transformation of E. coli (Hanahan) . . . . . . . . . . 26
3.4.3 Colony PCR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
3.4.4 Plasmid Preparation from E.coli Cells . . . . . . . . . . . . . . . 26
3.4.5 Subcloning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
3.4.6 List of Constructs . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
3.5 Heterologous Protein Expression . . . . . . . . . . . . . . . . . . . . . . 30
3.5.1 Cld from Candidatus Nitrospira defluvii (NdCld) - wild-type and
mutants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
3.5.2 Cld from Candidatus Nitrospira defluvii without heme (apo-NdCld) 30
3.5.3 Cld from Nitrobacter winogradskyi (NwCld) . . . . . . . . . . . . 31
3.6 Protein Purification Techniques . . . . . . . . . . . . . . . . . . . . . . . 31
3.6.1 Purification of NdCld Mutants . . . . . . . . . . . . . . . . . . . 31
3.6.2 Purification of Apo-NdCld . . . . . . . . . . . . . . . . . . . . . 33
3.6.3 NdCld with Co-Protoporphyrine IX . . . . . . . . . . . . . . . . 34
3.6.4 Purification of NwCld . . . . . . . . . . . . . . . . . . . . . . . . 34
3.7 Analytical Size Exclusion Chromatography . . . . . . . . . . . . . . . . 35
3.8 Crystallographic Techniques . . . . . . . . . . . . . . . . . . . . . . . . . 36
3.8.1 Crystallization of NdCld Mutants and Apo-NdCld . . . . . . . 36
v
Contents
3.9 Structure Determination and Refinement Techniques . . . . . . . . . . 37
3.9.1 Data Collection and Processing . . . . . . . . . . . . . . . . . . . 37
3.9.2 Molecular Replacement, Model Building and Refinement . . . . 38
3.10 Enzymatic Activity Techniques . . . . . . . . . . . . . . . . . . . . . . . 38
3.10.1 Steady-state Kinetics . . . . . . . . . . . . . . . . . . . . . . . . . 38
3.11 Biophysical characterizations . . . . . . . . . . . . . . . . . . . . . . . . 39
3.11.1 Static Light Scattering . . . . . . . . . . . . . . . . . . . . . . . . 39
4 Results 41
4.1 Structural Studies of NdCld Mutants . . . . . . . . . . . . . . . . . . . . 41
4.1.1 Structure of the W145V mutant in Complex with Imidazole . . 46
4.1.2 Structure of the W146Y Mutant in Complex with Imidazole . . 47
4.1.3 Structure of the R173E Mutant in Complex with Acetate . . . . 47
4.1.4 Structure of the W146Y R173Q Double Mutant in Complex with
Imidazole . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
4.2 Steady-state Kinetics of NdCld, Mutants and Variants . . . . . . . . . . 50
4.3 Structure of apo-NdCld . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
4.4 Stability of the NwCld Dimer . . . . . . . . . . . . . . . . . . . . . . . . 60
5 Discussion 65
5.1 Arginine 173 Mutations have Severe Effects on the Enzymatic Activity 65
5.2 Investigation of Additional Signature Residues . . . . . . . . . . . . . . 66
5.3 Mimicking the Active Site of Cld-like Proteins . . . . . . . . . . . . . . 68
5.4 Exchanging Iron to Cobalt Leads to Decreased Substrate Binding . . . 71
5.5 The Structure of Apo-NdCld . . . . . . . . . . . . . . . . . . . . . . . . . 71
5.6 Mixed Nature of the NwCld Dimer Interface . . . . . . . . . . . . . . . 72
6 Conclusions 73
References 75
List of Figures 80
List of Tables 82
Nomenclature 83
Acknowledgements 85
Curriculum Vitæ 87
vi
Contents
Zusammenfassung
Das Enzym Chloritdismutase (Cld), eine Oxidoreduktase, katalysiert den
Abbau von Chlorit zu Chlorid und molekularem Sauerstoff.Es ist hiermit
eines von drei bekannten Enzymen, welches die Bildung einer moleku-
laren Sauerstoffbindung als primäre Funtion durchführt. Ursprünglich waren
Clds nur aus Perchlorat-respirierenden Bakterien (PCRB) bekannt, wo sie
die Selbstvergiftung der Bakterien durch Abbau von cytotoxischem Chlo-
rit, welches als Produkt der (Per)chloratreduktion entsteht, verhindern.
Belastung des Trinkwassers durch anthropogenes (Per)chlorat wurde in
den letzten 50 Jahren zu einer zunehmenden Bedrohung der öffentlichen
Gesundheit in den Vereinigten Staaten. Bioremediation wäre ein geeignetes
Mittel zur Entgiftung. Im Jahr 2008 wurden Cld - Homologe nicht nur in
PCRBs, sondern in einer Vielzahl von Bakterien- und Archaeenstämmen
entdeckt. Sie bilden nun die Chloritdismutase-Überfamilie, deren Mitglieder
CFPs (Chlorite dismutase family proteins) genannt werden. Nur ein klein-
er Anteil dieser katalysieren den Abbau von Chlorit; die Funktion der
meisten ist noch unbekannt, auch wenn z.B. das CFP aus L. monocyto-
genes essentiell für das Pathogen ist und damit einen Ansatzpunkt für
Medikamentenentwicklung bieten könnte. Um Chloritdismutaseaktivität
in sequenzbasiert in CFPs vorhersagen zu können, wurden konservierte
und teilweise konservierte Aminosäurereste identifiziert und als mögliche
Signaturreste für Cld-Aktivität vorgeschlagen. In dieser Arbeit wurden
diese Aminosäurereste in der Cld von Candidatus Nitrospira defluvii, eines
wichtigen nitrifizierenden Klärbakteriums durch ortsspezifische Mutage-
nese ausgetauscht. Die Mutanten wurden durch biochemische Enzymak-
tivitätsmessungen und Röntgenkristallografie charakterisiert. Die wichtige
Rolle des zuvor identifizierten Aminosäurerests Arginin 173 wurde nochmals
bestätigt und erweitert. Für elf Mutanten und eine Cobalt Protoporphyrin
IX Variante wurden Fliessgleichgewichtskinetiken gemessen und die Struk-
tur vierer Mutanten sowie der apo-Variante von NdCld wurde durch Rönt-
genkristallografie gelöst. Des weiteren wurde die Relevanz elektostatis-
cher bzw. hydrophober Interaktionen, welche zur Stabilität der dimeren
Chloritdismutase von Nitrobacter winogradskyi beitragen, untersucht.
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Abstract
The enzyme chlorite dismutase (Cld), a heme b binding oxidoreductase,
catalyzes the degradation of chlorite to chloride and molecular oxygen.
It is therefore one of three known enzymes catalyzing the formation of a
molecular O-O bond as its primary function. Clds were originally thought
to be present in (per)chlorate respiring bacteria (PCRB), where they pre-
vent self-toxification of the bacteria by degradation of cytotoxic chlorite,
which is formed as a product of (per)chlorate reduction. Because freshwa-
ter pollution by anthropogenic perchlorate has become a serious public
health threat in the United States, bioremediation would present an effi-
cient method of detoxification. In 2008, many homologues to Cld were
discovered not only in PCRBs, but in a large number of diverse bacterial
and archaeal phylae. They comprise now a chlorite dismutase superfam-
ily, whose members are called CFPs (Chlorite dismutase family proteins).
Only a small subset of those were found to degrade chlorite, the function
of the large moiety remains unknown, though e.g. the CFP from L. mono-
cytogenes was shown to be essential for the organism, making the protein a
suitable drug target. To predict chlorite dismutase activity in CFPs on a se-
quence basis, conserved and partially conserved residues were previously
identified and suggested as possible signature residues for Cld activity.
In this work, these residues in the active site of the Cld from Candidatus
Nitrospira defluvii (NdCld), a key nitrifier in wastewater treatment, were
exchanged by site-directed mutagenesis and the mutants characterized by
biochemical enzyme activity assays (steady-state kinetics) and structurally
by X-ray crystallography. The role of the previously identified catalytic
residue arginine 173 was confirmed and steady-state kinetics measured
for eleven mutants and a cobalt protoporphyrine IX variant of NdCld. The
structure of four mutants and apo-NdCld was solved by X-ray crystallog-
raphy. In addition, the respective contributions of electrostatic and hy-
drophobic interactions to the stability of the dimer interface in the chlorite
dismutase from Nitrobacter winogradskyi were experimentally determined.
viii
1 Introduction
1 Introduction
1.1 Oxochlorates
Oxochlorates are the oxyanions derived from chlorine oxoacids, which are: i) per-
chloric acid (HClO4, a strong acid), ii) chloric acid (HClO3, also a strong acid), iii)
chlorous acid (HClO2, a weak acid) and iv) hypochlorous acid (HClO, a weak acid).
Oxochlorate salts are strong oxidizers, a property which leads to their widespread
use in industry.
Pollution with oxochlorates, especially perchlorate in drinking water has become a
serious problem in the United States. This large scale oxochlorate contamination was
found to be anthropogenic and potentially threatening to human health [7, 46, 49].
It was shown by Tonacchera et al. [45] that the affinity of the human sodium/iodide
symporter (NIS) in the thyroid gland for ClO−4 exceeds its affinity for I
− by thirty
times, due to ClO−4 having a similar size to I
− [49], making perchlorate a goitrogenic
substance. This has been therapeutically used in cases of hyperthyroism [51] in order
to disrupt the production of the thyroid hormones thyroxine and triiodothyronine,
but this therapy has also caused fatal bone marrow changes with doses of ClO−4 as
high as 6 mgkg∗day over a two-month period [48]. Chlorate and chlorite (ClO
−
2 ) cause
hemolytic anemia and have general cell-damaging effects [9, 47, 48]
Most perchlorate found on the planet is man-made and only entered the enviroment
recently, the sole bigger natural source being found in mineral deposits in Chile,
which contain up to 0.3 (w/w)‰perchlorate [8, 31]. Perchlorate is industrially pro-
duced by electrolysis of the other oxochlorates and is highly used e.g. as anti-microbial
agent, bleaching agent and NH4ClO4 as an additive to rocket fuel [48, 49]. Chlorite
(ClO−3 ) is used as a herbicide and is formed as a by-product of bleaching in the paper
industry [5].
The oxyanions of the chlorine oxoacids are very stable in enviromental conditions,
which, considering their threatening nature for human health, greatly increases the
need for an effective way of degradation. Bioremediation using perchlorate-reducing
microorganisms is a good way to tackle this problem [55], because physical and chem-
ical technologies have proven to be difficult or failed [8].
1
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1.2 Microbial Perchlorate Respiration
Oxochlorates possess a high reduction potential (ClO−4 /Cl
− E0=1.287 V; ClO−3 /Cl
−
E0=1.03 V), which renders them on the one hand potentially dangerous substances
(Section 1.1), but on the other hand they are suitable as electron acceptors for bacterial
metabolism [8]. This is utilized by (per)chlorate reducing bacteria (PCRB), which
are widely distributed in the proteobacterial phylum. PCRBs use this pathway for
anaerobic respiration, with (per)chlorate being the terminal electron acceptor (Figure
1). Suitable electron donors include e.g. acetate, lactate, ethanol or H2 [8].
Figure 1: Overview of the perchlorate reduction pathway in PCRB. Emphasized is the role
of chlorite dismutase, which detoxifies ClO−2 produced by (per)chlorate reductase.
Figure adapted from Coates and Achenbach [8].
The (per)chlorate reduction pathway consists mainly of two enzymes: i) (per) chlo-
rate reductase (PerR) and ii) chlorite dismutase (Cld).
Perchlorate reductases catalyze the degradation of perchlorate and chlorate to chlo-
rite. They are homologs to bacterial nitrate reductases, used by bacteria for nitrate
respiration. It was speculated by Kengen et al. [28] that PerR evolved from nitrate
reductases, Goblirsch et al. [17] propose that PerR evolved from DMSO reductase via
gene duplication. PerR are promiscous enzymes with many of them being able to
reduce nitrate, iodate and bromate besides (per)chlorate. Some PCRB are capable of
nitrate respiration as well[8].
Essential for the degradation of (per)chlorate to chloride is the enzyme chlorite dis-
mutase (Cld), which catalyzes the degradation of chlorite to chloride and molecular
oxygen (see Figure 2) and thus prevents self-toxification of PCRB. Chlorite dismu-
tase was first described by van Ginkel et al. [52] in the (per)chlorate-respiring strain
2
1 Introduction
GR-1 (Azospira oryzae, DSM 11199). Most PCRB are facultatively anaerobic or mi-
croaerophilic organisms, so the molecular oxygen produced by the Cld is usually an
intermediate and subsequently further converted to H2O [8].
Figure 2: Schema of the microbial perchlorate-reducing pathway.
The catalyzed chlorite dismutase reaction is not a dismutation, but an intramolecu-
lar redox reaction. Therefore, the name chlorite dismutase is misleading and a more
correct name besides the systematic identifier chlorite:oxygen oxidoreductase would be
chlorite-O2-lyase1 [20]. However, the term chlorite dismutase is still more prevalent in
the literature and will be used throughout this thesis. Chlorite dismutase is a unique
enzyme that does not share sequence similarities or obvious evolutionary relation-
ships with other well-researched proteins. It is also very substrate specific and not
promiscuous, unlike (per)chlorate reductase or nitrate reductase.
1EC 1.13.11.49 according to IUBMB
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1.3 Diversity of Chlorite Dismutases
Chlorite dismutases were first found in PCRBs, where they are essential for the bac-
terial metabolism by detoxifying ClO−2 to Cl2 and O2 and where they were used as
markers for the ability of an organism to respire (per)chlorate [3].
Enviromental genomics approaches revealed many homologs of chlorite dismutase
genes in non-perchlorate reducing prokaryotes, distributed both in bacterial and ar-
chaeal phylae [32]. All these genes comprise now their own chlorite dismutase super-
family, and Goblirsch et al. [17] refer to them as Cld family proteins (CFPs). Phyloge-
netic trees comparing the Cld lineage to the 16SrRNA reveal hardly any lateral gene
transfers (Figure 3), which indicates that Cld homologues were present in early com-
mon ancestors of Archaea and Bacteria [32]. Chlorite degradation has been observed
in only a small subset of these proteins, the validated Clds, but the functions of the
others remain still unknown. These CFPs were termed Cld-like proteins [34]. Sev-
eral factors indicate that the capability to degrade chlorite was only recently acquired
by this superfamily of proteins: i) perchlorate is a recent anthropogenic enviromen-
tal pollutant, only a small, specialized number of the very diverse organisms with
cld genes are associated with perchlorate respiration and an evolutionary pressure to
detoxify chlorite. ii) the cld gene is localized in PCRBs in the PerR operon, which it
entered by lateral gene transfer [8].
Functional and structural studies on validated chlorite dismutases and presumably
non-functional CFPs lead to the suggestion of signature residues that could predict
the catalytic activity of chlorite dismutases on a sequence basis [17, 29, 32, 34]. One
important key residue is an arginine in the distal pocket of the active site (Details in
Section 1.4), which was shown to have dramatic influence on the catalytic effiency of
Cld [29]. Figure 3 gives detailed information about the nature of this residue in Clds
and Cld-like proteins.
In the phylogenetic tree (Figure 3) from Kostan et al. [29], validated active chlorite
dismutases are clustered together and closely related; there are the chlorite dismu-
tases from PCRBs. The Clds from Azospira oryzae (AoCld) and Dechloromonas aromat-
ica (DaCld, not in Figure 3) have been structurally characterized [12, 18], the Cld from
Ideonella dechloratans is also well-researched [40]. Active chlorite dismutases have also
been found in non-PCRBs, with the best-researched being the chlorite dismutases
from nitrite-oxidizing bacteria (NOB). The Cld from Nitrospira defluvii (NdCld) was
the first Cld from a non-proteobacterial organism that was discovered and whose
the structure was determined. The structure of the Cld from Nitrobacter winograd-
skyi (NwCld) was published shortly afterwards. Based on the phylogenetic analyses,
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Figure 3: Phylogenetic tree of Clds and Cld-like proteins. The alignment is based on the
amino acid sequence of the protein. Colours indicate different bacterial or archaeal
phylae based on 16S rRNA. The coloured bars indicate the identity of the residue
homologous to arginine 173 in NdCld, which was postulated to be a key residue for
the chlorite dismutase reaction. Stars indicate proteins with determined structure
(The CFP from Dechloromonas aromatica is missing in this tree). Figure adapted from
Kostan et al. [29].
Mlynek et al. [34] suggested a classification of the validated and proposed active chlo-
rite dismutases into two lineages; with Lineage I containing the canonical Clds, being
mainly from PCRB - NdCld comprising the only non-proteobacterial member of this
lineage and Lineage II, where NwCld and related proteins are located.
Apart from the cluster of validated and postulated active chlorite dismutases, where
all proteins share the common catalytic arginine, there exists a multitude of CFPs with
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a different signature residue at the position corresponding to this catalytic residue
(see Figure 3). A large cluster, containing mainly CFPs from Firmicutes, but also
from Deinococcus, Planctomycetes, Verrucomicrobia, Thermus and even Archaea features a
common glutamine residue instead of the arginine. In this “glutamine” cluster, many
CFPs from human pathogens, e.g. Listeria monocytogenes and Staphylococcus aureus are
located. The CFP from Listeria monocytogenes has a yet unknown function, no chlorite
dismutase activity could be observed (and it does not match the proposed signature
residues), but it was shown to be essential for this organism. (Füreder, unpublished
data), which renders it a potential drug target. Listeria is a human facultative intra-
cellular pathogen, causing potentially fatal listeriosis via the uptake of contaminated
food. The other clusters in the phylogenetic tree, which are less well-characterized,
contain proteins from Actinobacteria, with Mycobacterium leprae and Mycobacterium tu-
berculosis as human pathogens being the most prominent representatives. They fea-
ture mostly alanine instead of the signature arginine. A forth larger cluster, with the
signature residue arginine replaced by a serine, is of archaeal origin. Other archaea
exhibit leucine at this position.
CFPs comprise a manifold plethora of proteins distributed over many bacterial phy-
lae that share a common, ancient fold and sequence similarities. The function of the
majority of CFPs remains shrouded in mystery, despite being of great importance to
e.g. L. monocytogenes, while validated or even canonical chlorite dismutase account
only for a tiny subset of CFPs.
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1.4 Structure of Chlorite Dismutases
Early Cld research determined the molecular mass of the protein, originating from the
strain GR-1 (Azospira oryzae) and claimed it to be homotetrameric, based on its reten-
tion volume on a size exclusion chromatography column [52]. When the first X-ray
diffraction structures of Clds and Cld-like proteins were determined, the structures
revealed the enzymes to be pentameric or hexameric (but pentameric in solution)
[12, 13, 18, 29]. All structurally characterized canonical Clds (and Cld-like proteins)
share a common, characteristic fold.
The structure of a single subunit (Figure 4) reveals two sequential ferredoxin-like
folds. The ferredoxin-like fold (Figure 5) is a α+β fold with an βαββαβ signature sec-
ondary structure, with the β-strands arranged in the order 4↓1↑3↓2↑. The β-strands
form an antiparallel β-sheet with the α-helices packing against one side of the sheet.
Figure 4: Subunit structure of chlorite dismutase from Candidatus Nitrospira defluvii with an-
notated secondary structure elements. The heme b group is shown as a stick model
in the C-terminal domain. The structure of NdCld was solved by X-ray diffraction
at 1.8Å and the protein was revealed to be a homopentamer. Figure adapted from
Kostan et al. [29]
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Figure 5: Topology of the ferredoxin-like fold. It is an α+ β fold with a signature secondary
structure motif βαββαβ. The β-strands form an antiparallel β-sheet with the helices
packed on one side.
The central core of a Cld subunit is formed by the two antiparallel β sheets that stack
top of each other at an angle of≈ 65◦to form a flattened β-barrel. They are surrounded
by a variable number of flanking α-helices. The Cld subunit consists thus of two
structurally similar domains. The subunit fold is highly conserved, with the single
subunits of other Clds and Cld-like proteins diverting only with an r.m.s.d. of 1.72Å
(over 180 Cα atoms [29].
An exception to the described tertiary and quarternary structure is the already men-
tioned chlorite dismutase from Nitrobacter winogradskyi (NwCld) [34], whose the amino
acid sequence is about one-third smaller than of all other structurally characterized
Cld and Cld-like proteins and misses the α-helices of the N-terminal ferredoxin-like
fold entirely. The N-terminal β-sheet and the C-terminal domain are preserved in
NwCld. The shorter sequence takes its toll on the subunit interface; NwCld forms a
dimer instead of a pentamer or a hexamer (see Figure 6). Mlynek et al. [34] suggest
that the N-terminal part was lost during evolution. Nevertheless, NwCld is a highly
active chlorite dismutase.
Four structures are known of CFPs that have no heme and have been observed to have
no or only a very weak Cld activity. The structure of the already introduced LmCld
was recently determined (Mlynek, unpublished data), with the heterologously ex-
pressed protein having no heme in its active site. Phylogenetically LmCld belongs
to the previously described large group of CFPs, where the signature residue argi-
8
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nine is a replaced by a glutamine. Two more representatives of this group have been
structurally characterized: The protein TT1485 from a thermophile, Thermus ther-
mophilus[13]. The crystal structure of this protein did also not feature a heme; but
in silico docking of a heme group was successful and the protein could be in vitro
reconstituted with hemin; then exhibiting a very weak chlorite dismutase activity.
Ebihara et al. [13] propose that TT1485 might bind heme c, which was proposed to
be covalently bound via a single thioether bond. The other structure, from the ther-
mophile firmicute Geobacillus stearothermophilius was solved by a structural genomics
consortium (Gilski et al., [2004]). In addition, the structure of the CFP from Thermo-
plasma acidophilum was solved, also by means of structural genomics (Chang et al.,
[2008]). The CFP of T. acidophilum belongs to the archaeal “serine“ cluster. No heme
was found in its active site.
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Figure 6: All hitherto known structures of Clds and Cld-like proteins. The confirmed Clds
are from the following organisms: Dechloromonas aromatica and Azospira oryzae are
confirmed PCRB, Candidatus Nitrospira defluvii and Nitrobacter winogradskyi are NOB.
The rest are Cld-like proteins, not having a catalytical arginine and no or only very
weak Cld activity: Listeria monocytogenes a firmicute and human pathogen Thermus
thermophilus, a thermophile bacterium, Geobacillus stearothermophilus, a thermophile
firmicute and Thermoplasma acidophilum, an thermophile archaeon.
10
1 Introduction
1.5 Active Site
One chlorite dismutase subunit consists of two similar ferredoxin-like domains, but
only one heme is bound in confirmed Clds in a cavity formed by the second, C-
terminal β sheet and its flanking helices. It is enclosed by the central C-terminal
β-sheet (β1’, β2’,β3’) and by helices α6, α1’ and α3’. Central to heme binding is the
proximal histidine in α3’, which coordinates the iron as an axial ligand. The second
ferredoxin-like fold lacks this histidine and is therefore unlikely to bind a heme. On
the distal site of the heme is the proposed substrate binding site. The active site dis-
played in Figures 7 and 8 shows that the iron atom in the heme is hexacoordinated in a
quadratic-bipyramidal (octaedric) way. The four nitrogen atoms of the pyrrol groups
of the porphyrin ring comprise the equatorial ligands. The axial ligands are histi-
dine on the proximal side and substrate/inhibitor/water on the distal side (Figure 7).
Until now, there exists no Cld structure with substrate, product or an intermediate
bound. Instead, either the inhibitors imidazole, cyanide [29], thiocyanate [12], nitrite
[18] or simply water [34] have been observed to occupy the active site. The Cld-like
protein from Geobacillus stearothermophilus crystallized with PEG 330 in the active site
cavity in validated Clds (Gilski et al, [2004], PDB: 1T0T).
Figure 7: Octaedric coordination of the iron in the active site of the Canditatus Nitrospira de-
fluvii chlorite dismutase. Four nitrogens from the pyrrol rings serve as equatorial
ligands, the proximal histidine and the inhibitor imidazole as axial ligands.
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Figure 8: Overview of the active Site of chlorite dismutase from Candidatus Nitrospira deflu-
vii in complex with imidazole as distal axial ligand. Chain A is visible in light
grey in the background. Mauve residues are proposed signature residues for chlo-
rite dismutase activity in CFPs, green residues are conserved throughout all CFPs.
Residues 107-112 are not visible in the background cartoon structure.
12
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1.6 Reaction Mechanism
Chlorite dismutase is remarkable from a biochemical point of view, as it is one of three
known enzymes that catalyze the formation of a covalent O-O bond as their principal
function, the other two being water:plastoquinone oxidoreductase (photosystem II)
and a yet uncharacterized enzyme from an anaerobic methane-oxidizer [15, 36].
Lee et al. [31], Streit and DuBois [43] proposed a reaction mechanism similar to heme
peroxidases and catalases (see Figures 9 and 10 as well as Equation 1), which was
further explored by Kostan et al. [29], Mlynek et al. [34] and Goblirsch et al. [18].
E + ClO−2
k1
GGGGBF G
k-1
[E · ClO−2 ]
k2
GGGA[CompoundI + ClO−]
k3
GGGAE + Cl− +O2 (1)
The reaction cycle starts with a pentacoordinated iron in ferric (III) state. Initial ClO−2
binding leads to hexacoordination and formation of the Michaels intermediate (Fig-
ure 9), which was proposed to occur in a simple, reversible collision complex model
[43]. An oxoiron(IV) porphyrin pi-cation radical complex (Compound I, FeIV=O,
por·+), which is two oxidizing equivalents above the resting state, is then formed
by heterolytic cleavage of a Cl-O bond. The rate of the conversion of the Michaelis
intermediate to compound I + ClO− (k2) was suggested to be the limiting step of
the reaction [43]. Afterwards, a nucleophilic attack of the intermediate hypochlorite
(ClO−) on Compound I leads to the formation of a rapidly decaying peroxychlorite
anion, yielding the release of the products O2 and Cl− from the active site and return-
ing the iron to ferric state with a two-electron reduction that completes the cycle. An
alternative pathway suggested by Goblirsch et al. [17] starts from homolytic cleavage
of the Cl-O bond, resulting in a hypochloryl radical (• O-Cl) and the ferryl-porphyrin
complex (Compound II, FeIV=O, por). The subsequent recombination of these leads
also to product formation and release via the decay of the peroxychlorite anion.
A side path displayed in Figure 9 involves the formation of a tryptophanyl radical,
which is also associated with formation of compound II [31, 43] and leads to degra-
dation of the heme and therefore bleaching and inactivation of the enzyme. Both
compound I and II have been detected spectroscopically (EPR, UV-VIS) in chlorite
dismutases [31] and have even been trapped in a crystal structure in heme peroxi-
dases [19], where compound II formation is part of the reaction cycle that reduces the
enzyme back to its resting state via a two-step reduction[53]. Class I heme peroxi-
dases use a Trp residue as site of the cation radical [39]. Figure 9 displays a compact
overview.
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Figure 9: Possible reaction mechanisms for chlorite dismutases. a) Heterolytic cleavage of the
Cl-O bond pathway yields compound I, b) Homolytic cleavage of the Cl-O bond
yields compound II, c) Inactivation of Cld and heme degradation occurs via the off-
pathway production of a tryptophanyl radical and compound II. Figure adapted
from Goblirsch et al. [17, 18]
Figure 8 shows the active site of the chlorite dismutase from N.defluvii with its side
chains closest to the heme, including the residues which were proposed to be signa-
ture residues for active chlorite dismutases [17, 34].
Central to heme binding is the proximal histidine, His 160, which contributes to iron
coordination via its imidazole side chain, therefore serving as its axial ligand. This
histidine is linked to several active site residues via an intricate hydrogen bonding
network. Its imidazolic character is proposed to be enhanced by the neighboring Glu
210, to which it forms a hydrogen bond [29]. The residue Lys 141 donates a hydrogen
bond to Glu 210.
The conserved arginine residue in the distal pocket (Arg 173) was shown to play a
significant role in the reaction. If this residue is exchanged, the ability of Cld to bind
and process its substrate is greatly reduced [29]. In the structure it points away from
the active site with imidazole as the axial ligand. Its positive charge is supposed
to position and stabilize the substrate and intermediates [34]. Figure 10 shows the
proposed compound I path of the proposed reaction mechanism with emphasis on
the role of arginine [34].
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Figure 10: Proposed reaction mechanism of chlorite dismutation emphasizing the role of argi-
nine in the distal pocket. Figure adapted from Mlynek et al. [34]
Ile 137 and Leu 168 are two hydrophobic residues that were also suggested to be
signature residues for chlorite dismutase activity [34], comprising a favourable envi-
ronment to the binding of heme, that does not lead to clashes.
Table 1: Signature residues (according to Mlynek et al. [34]) in the active site for active chlo-
rite dismutases and other conserved residues for CFPs. All residues are numbered
according to the N. defluvii numbering. His 214 and Trp 217 are only conserved
throughout PCRB, in N. defluvii they are changed to an asparagine and a phenylala-
nine, respectively
Residue Conservation status proposed function
Ile 137 signature residue heme stability, ligand cavity size
Lys 141 all CFPs proximal H-bonding network
Trp 145 all CFPs radical pathway
Trp 146 signature residue radical pathway
His 160 all CFPs proximal axial ligand for heme
Leu 168 signature residue heme stability, ligand cavity size
Arg 173 signature residue catalytic function
Gln 210 signature residue proximal H-bonding network
His 214 PCRBs radical pathway
Trp 217 PCRBs radical pathway
The Trp residue required for the off-reaction formation of compound II and subse-
quent bleaching should be located near the active site and close to the propionate
groups of the heme for electron transfer [25]. All Clds and Cld-like proteins have at
least one conserved Trp in the vicinity of the active site, validated ones always bear
two neighboring Trp residues [29], which are oriented orthogonally to each other (see
Figure 8, residues Trp 145 and Trp 146) [43]. A third Trp and a His residue (Trp 224
and His 227 in DaCld numbering, corresponding to Asn 214 and Phe 217 in NdCld)
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neighboring the juxtaposed pair of Trp residues are conserved throughout Clds from
PCRBs and could be additionally involved in radical formation, comprising a conti-
nous path for the electron [17].
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2 Aim of this Thesis
The aim of this thesis was to elucidate reaction mechanism details of chlorite degra-
dation by the enzyme chlorite dismutase via a comprehensive structural, biochemical
and genetic approach.
Section 4.1 and 4.2 describe the mutational studies on the proposed chlorite dismutase
“fingerprint” residues in combination with biochemical enzyme activity assays that
were conducted to confirm the relevance of these amino acids for the chlorite dismu-
tase reaction. Also, structural studies were performed on these mutants to see effects
of the mutations in the active site. One goal was to generate a NdCld variant suit-
able for gaining structural insights into the chlorite dismutase reaction, i.e. trapping
substrate bound states or reaction intermediates in a crystal structure. While this was
not achieved, the generated mutants provide insights about the reaction mechanism
and important residues and will be utilized for further biochemical and structural
studies.
In section 4.3 the successful preparation and crystal structure of the N. defluvii chlorite
dismutase without heme b is presented. Apo-NdCld was used as an intermediate for
the production of NdCld with a different prostethic group, cobalt protoporphyrine
IX, contributing to the mutational studies summarized before. The structure of apo-
NdCld was determined to gain insights into the heme environment and for compari-
son with CFPs where no heme binding has been observed.
The study described in Section 4.4 emerged from the Nitrobacter winogradskyi chlorite
dismutase project. Here, the stability of the subunit interactions in NwCld was exper-
imentally determined. Therefore, the contributions of electrostatic and hydrophobic
forces that account for the formation of the dimer, which are different from the sub-
unit contacts in pentameric chlorite dismutase were elucidated.
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3.1 Antibiotics, Media and General Buﬀers
Composition of all general buffers, stock solutions, media and antibiotics is described
in Tables 2 and 3.
Table 2: Stock solutions and used concentrations of antibiotics. All stock solutions were sterile
filtered (Ø 0.22 µm) before freezing. All antibiotics were purchased from Sigma.
Antibiotic Preparation
Ampicilin 100 mgml in H2O, stored at -20
◦C. Used 1:1000.
Kanamycin 100 mgml in H2O, stored at -20
◦C. Used 1:1000.
Chloramphenicol 34 mgml in ethanol, stored at -20
◦C. Used 1:1000.
Table 3: Preparation of general buffers, media and stock solutions.
Solution Preparation
LB-medium 10 g tryptone, 5 g yeast extract, 10 g NaCl, adjusted to pH
7.0 with NaOH (ready-made, Sigma, 30 g for 1000 ml H2O);
autoclaved.
LB agar 15 g agar dissolved in 1000 ml LB medium
PBS 137 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4 · 2H2O, 1.7
mM KH2PO4, pH 7.4. Used as PBS buffer tablets (Sigma).
One tablet is dissolved in 200 ml ddH2O.
50x TAE buffer 2 M Tris-HCl pH 8, 1 M acetic acid, 50 mM Na2-EDTA, pH
8.0. Used for preparation of agarose gels.
TE buffer 10 mM Tris-HCl pH 8.0, 1 mM EDTA
10x SDS running buffer 0.25 M Tris-HCl pH 8.3, 2 M glycine, 1% (w/v) SDS
Destaining Solution 250 ml ethanol, 50 ml acetic acid, filled to 1000 ml with H2O
Staining Solution 250 ml ethanol, 80 ml acetic acid, 2.5 g Coomassie brilliant
blue, filled to 1000 ml with H2O.
Hemin 50 mgml in 0.1 N NaOH, used 1:1000, unless stated otherwise.
Always freshly prepared, short-term storage at 4◦C. Pur-
chased from Fluka.
Cobalt protoporphyrine
IX
Powder stored at 4◦C, stock solution of 5-10 mgml in 0.1 N
NaOH. Freshly prepared, short-term storage at 4◦C. Pur-
chased from Fluka.
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3.2 Expression System and Expression Vectors
Several laboratory strains of the bacterium Escherichia coli were used as system for
genetic manipulation (subcloning and mutagenesis) as well as heterologous protein
expression system throughout this thesis. The strains are summarized in Table 4.
The expression vectors all carry a copy of the lacI gene for the lac-repressor and
thus are all inducible by addition of lactose or the artifical inducer Isopropyl-beta-
D-thiogalactopyranoside (IPTG).
Table 4: Escherichia coli host strains used for cloning and expression.
Host strains Genotype Usage
DH5α F−, φ80∆lacZ∆M15∆(lacZYA-argF)U169
deoR recA1 endA1 hsdR17(rk-mk+) phoA
supE44 thi-1 gyr A96 relA1
Cloning
XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44
relA1 lac [F’ proAB lacIqZ∆M15 Tn10
(Tetr)]
Cloning
Tuner (DE3) (Novagen) F− ompT hsdSB (r−B m
−
B ) gal dcm lacY1
(DE3)
Expression
Rosetta™2 (Novagen) F− ompT hsdSB(r−B m
−
B ) gal dcm pRARE2
(CamR)
Expression
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3.3 Storage
Proteins Short-term storage of proteins was either done on ice or at 4◦C, e.g. during
purification. For long-term storage, protein samples were aliquoted to 100 µl in thin-
walled 500 µl reaction tubes, flash-frozen in LN2 and stored at -80◦C.
DNA DNA samples in 1xTE buffer were stored on 4◦C for short term (1-3 days) and
frozen at -20◦C for long-term storage.
Glycerol Stocks All constructs (see the construct list 10) were transformed into a
cloning strain (DH5α, XL-1 blue) and an expression strain (Tuner (DE3) or Rosetta™2).
The glycerol stock was created by pelleting 50 ml of a dense culture grown in selective
LB medium and resuspending the cell pellet in sterile 15% (v/v) glycerol, aliquoting
to 500-1000 µl into 1 ml cryotubes (Nunc) and flash-freezing in LN2. Stocks were
stored at -80◦C.
Buﬀers and Stock Solutions Sterile filtered buffers and stock solutions were stored
at room temperature. Buffers and solutions used for protein purification or protein
crystallization at 4◦C were cooled down before usage. PEG stocks were stored pro-
tected from light.
3.4 Molecular Cloning Techniques
Molecular cloning techniques were mainly used to introduce specific mutations into
the cld gene from Candidatus Nitrospira defluvii and to change expression vectors from
pETM-11 to the custom StrepTEVpET21 expression vector.
DNA concentration was determined spectroscopically with a NanoDrop 2000c (Ther-
moFisher Scientific), unless stated otherwise. All restriction enzymes and T4 ligase
were purchased from Fermentas, as well as the appropriate buffers.
All oligonucleotides were ordered at Sigma-Aldrich on a synthesis scale of 0.2 µmol,
purified by desalting. Upon arrival, the dry oligos were dissolved in 1xTE in an
appropriate volume to reach a concentration of 100 µM.
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3.4.1 Site-Directed Mutagenesis
To introduce the desired mutations of specific residues in the active site of NdCld,
site-directed mutagenesis via polymerase chain reaction (PCR) was employed. This
enables the targeted exchange of one or more base pairs in a DNA sequence with
designed primers. The mutagenesis primers containing the desired mutation were
designed as the reverse primer being the reverse complement of the forward and
thus complementary to opposite strands of the template vector. A complete primer
list is found in Table 5. Template vector was either the wild-type plasmid, pJK23 (see
Table 10) for single mutants or the appropriate single mutant construct for double
mutants.
Two different PCR setups were used for site-directed mutagenesis, the first utilizing
Pfu DNA polymerase from Pyrococcus furiosus (Fermentas), the second using the 2x
PhusionFlash MasterMix (Finnzymes). The latter was used prevalently because of the
easier handling and the faster polymerase (Pfu: 1 kbmin ; PhusionFlash: 4
kb
min ). The PCRs
were carried out on an Eppendorf Mastercycler gradient PCR machine. After the PCR
reaction, the PCR reaction mix was treated with the DNA restriction enzyme DpnI at
37◦for 1 hour. DpnI (recognition sequence: 5’-GmeA’TC-3’) digests the methylated
wild-type DNA and leaves only the mutated plasmid generated by the mutagenesis
PCR. This mixture, containing the nicked mutated vector DNA, was subsequently
transformed into DH5α chemically competent E.coli cells.
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Table 5: Primers (Sigma-Aldrich) used for site-directed mutagenesis of NdCld (top, with the
mutated triplet indicated in green) or for specific amplification of a Cld insert (bot-
tom). All primers were ordered dry and dissolved in the appropriate amount of 1xTE
buffer to a concentration of 100 µM upon arrival. Primers for NwCld and LmCld are
used to amplify the respective gene and fit it with NcoI/XhoI restriction sites for use
with appropriate expression vectors, e.g. StrepTEVpET21 or pETM-11. The melt-
ing temperature was calculated as the salt-adjusted TM with the Promega BioMath
Calculator.
Name Primer sequence TM (◦C)
W145V fwd 5’-GAAGGACGCGGAAGTGTGGGCACTGGACCAGG-3’ 66
W145V rev 5’-CCTGGTCCAGTGCCCACACTTCCGCGTCCTTC-3’ 66
W145F fwd 5’-TCCCTATCAAGAAGGACGCGGAATTTTGGGCACTG-3’ 62
W145F rev 5’-CAGTGCCCAAAATTCCGCGTCCTTCTTGATAGGGA-3’ 67
W146Y fwd 5’-GAAGGACGCGGAATGGTACGCACTGGACCAGG- 3’ 64
W146Y rev 5’-CCTGGTCCAGTGCGTACCATTCCGCGTCCTTC-3’ 64
VY fwd 5’-GAAGGACGCGGAAGTGGCACTGGACCAGG-3’ 63
VY rev 5’-CCTGGTCCAGTGCGTACACTTCCGCGTCCTTC-3’ 64
R173E fwd 5’-CCTATCTGAAGACGGTGAAAGAA
AAACTGTATCATTCGACGGG-3’
62
R173E rev 5’-CCCGTCGAATGATACAGTTTTTCTTT
CACCGTCTTCAGATAGG-3’
62
R173Q fwd 5’-CTGAAGACGGTGAAACAAAAACTGTATCATTCG-3’ 56
R173Q rev 5’-CGAATGATACAGTTTTTGTTTCACCGTCTTCAG-3’ 56
E210A fwd 5’-CTGCAGCAGGTGAAGGCATTCCGCCACAATCGAC-3’ 64
E210A rev 5’-GTCGATTGTGGCGGAATGCCTTCACCTGCTGCAG-3’ 64
NwCld fwd 5’-GCTGAGCCATGGGGACGTTCACAGTCTTCACC-3’ 63
NwCld rev 5’-AGTTTCCTCGAGTCATATCGCGCGCGCCAATCGAAT-3’ 63
LmCld fwd 5’-GCTGAGCCATGGGGATGAGCGATTACGACATCCC-3’ 64
LmCld rev 5’-CCCCTCCTCGAGCTAAATAGTAAA
TAATTTAGAAAGTTG-3’
57
NdCld fwd 5’-GGAGATATACCCATGGCCGATC-3’ 55
NdCld rev 5’-TTCGGATCCTACTGTGCGAACT-3’ 55
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Table 6: PCR setups I and II for site-directed mutagenesis using Pfu DNA polymerase and
PhusionFlash DNA polymerase, respectively.
Component Concentration Volume Stock
PCR setup I
Forward primer 0.2 µM 1 µl 10 µM
Reverse primer 0.2 µM 1 µl 10 µM
Template 15 ng50µL 1 µl 15
ng
µL
10x Pfu buffer + MgSO4 1x 5 µl 10x
dNTPs 0.3 mM 6 µl 2.5 mM
Pfu 1 µl 2.5 UµL
dd H2O sterile ad 50 µl
PCR setup II
Forward primer 0.2 µM 1 µl 10 µM
Reverse primer 0.2 µM 1 µl 10 µM
Template 15 ng50µL 1 µl 15
ng
µL
2x PhusionFlash MasterMix 25 µl
dd H2O sterile ad 50 µl
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Table 7: PCR settings for site-directed mutagenesis for PCR setups (Table 6). Annealing tem-
peratures were calculated with the Promega BioMath calculators.
Process Temperature (◦C) Duration (sec)
Mutagenesis PCR for PCR setup I
Initial denaturation 95 ◦C 300
Denaturation 95 ◦C 30
Primer annealing x ◦C 45
Extension step 72 ◦C 360
Cycles 30
Final extension 72 ◦C 600
Cooling 4 ◦C hold
Mutagenesis PCR for PCR setup II
Initial denaturation 95 ◦C 300
Denaturation 95 ◦C 30
Primer annealing x ◦C 45
Extension step 72 ◦C 120
Cycles 30
Final extension 72 ◦ 300
Cooling 4 ◦C hold
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3.4.2 Chemical Transformation of E. coli (Hanahan)
100 µl of chemically competent cells [23] (stored at -80◦C) were thawed on ice, trans-
formed with 5-20 ng DNA (unless stated otherwise; 6 µl of DpnI-treated PCR product
after site-directed mutagenesis) and incubated on ice for 20 minutes. After a 60 s heat
shock (42◦C), the cells were incubated again for 3 minutes on ice. Subsequently, 900
µl nonselective LB medium was added and the cells put into recovery at 37◦C and
800 rpm for one hour. Afterwards, the cells were plated onto a selective agar plate
and grown in an incubator overnight at 37◦C.
3.4.3 Colony PCR
Presence of a specific insert was verified by performing PCR on colonies grown on
petri dishes before a small-scale DNA preparation for sequencing. For colony PCR,
single colonies were picked and resuspended each in a PCR tube in 5 µl sterile ddH2O.
2 µl of the cell suspension were subsequently dropped on a selective agar plate with
a grid to identify correct clones later on. A PCR mix was set up as described in Table
8, using generic primers for the respective gene(see Table 5) The PCR products were
analyzed on an 1 % agarose gel for the presence of a band at the corresponding size.
Clones containing the desired insert were used for inoculation of a small-scale culture
(see section 3.4.4).
Table 8: PCR setup for colony PCR.
Component Concentration Volume Stock
Cell suspension - 3 µl -
2x PhusionFlash MasterMix 1x 12.5 µl 2x
Primer fwd 0.8 µM 1 µl 10 µM
Primer rev 0.8 µM 1 µl 10 µM
dd H2O sterile ad 25 µl
3.4.4 Plasmid Preparation from E.coli Cells
Two different commercial kits were used for plasmid preparation from E.coli DH5α or
XL1-blue cells, depending on the needed plasmid yield. For identification of correct
clones and subsequent sequencing, small-scale minipreps were performed using the
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Table 9: PCR program used for colony PCR.
Process Temperature (◦C) Time (sec)
Cell lysis 98 ◦C 600
Initial denaturation 95 ◦C 120
Denaturation 95 ◦C 30
Annealing x◦C 54
Elongation 72 ◦C 60
Cycles 30
Final elongation 72 ◦ 180
Cooling 4 ◦C Hold
Plasmid Mini Kit from Fermentas. To produce a larger, stable DNA stock of a con-
firmed construct in transformation quality, medium-scale plasmid purifications were
done with the NucleoBond® Xtra Midi Kit from Macherey-Nagel.
Small-scale (Miniprep) For a miniprep, 5 ml of selective LB medium was inocu-
lated with a single colony and the culture grown shaking at 37◦C overnight in an in-
cubator. The dense cell culture was harvested by centrifugation next day (15 minutes
at 4000 rpm) and the plasmids purified according to the manufacturer’s instructions,
which utilizes the alkaline lysis method. The DNA was eluted from the spin colums
with 50 µl TE buffer.
Medium-scale (Midiprep) For larger amounts of plasmid DNA, 50-100 ml of se-
lective LB medium was inoculated with a single colony and the culture grown overnight
at 37◦shaking. The cells were harvested by centrifugation (4000 rpm, 25 minutes)
and the plasmids purified according to the manufacturer’s instructions. The plasmid
DNA pellet was resuspended in 100-150 µl TE.
3.4.5 Subcloning
The expression vector was changed from pETM-11 to a modified version of pET21(+)
with an N-terminal Strep-Tag II, cleavable by TEV protease. This vector will be re-
ferred to as StrepTEVpET21(+) throughout this thesis. The cld insert was cut out from
pJK29, pJK30, pJK32, pJK53, pJK54, pJK55, pKG1, pKG2, pKG3 and pKG5 (see Table
10) with the restriction endonucleases NcoI (5’-C’CATGG-3’) and XhoI (5’-C’TCGAG-
3’). The StrepTEVpET21 vector was treated with the same enzymes. The reaction mix
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consisted of 1 µg vector DNA, 5 µl 10x buffer R (Fermentas), 1 µl XhoI, 1 µl NcoI
(both Fermentas, 10 UµL ). Sterile ddH2O was added to a total volume of 50µl and the
reaction mix was incubated at 37◦C for 1 hour.
The digested DNA was purified with an 1% (w/v) agarose gel containing either 0.5
µg
ml ethidium bromide or SYBR® Safe DNA gel stain (Invitrogen, at a ratio of 1:10000)
for UV visualization of the DNA. The appropriate bands were cut out from the gel,
extracted with the GeneJET Gel extraction kit (Fermentas) and subsequently eluted
from the spin column in 20-30 µl TE.
The DNA yield was determined spectroscopically to set up the ligation reaction,
which consisted of 1 µl 10x T4 ligation buffer, digested vector and insert at a mo-
lar ratio of 1:4 with approx. 20 ng of vector, 0.5 µl T4 ligase and was adjusted with
sterile ddH2O to a total volume of 10 µl. The ligation reaction was incubated at 16◦C
overnight and the whole ligation mix subsequently transformed to either DH5α or
XL-1 blue.
An overview over all constructs is presented in Table 10.
3.4.6 List of Constructs
This table represents a comprehensive list of all the constructs used and created dur-
ing this thesis.
For the heterologous expression of the chlorite dismutase from N.defluvii (accession
no. ACE75544), Kostan et al. [29] used a truncated version of the gene which lacked
the first 26 N-terminal amino acids, which were predicted to be a signal peptide
for periplasmic localization, because the full-length protein was not functional. This
truncated gene in the pETM-11 (EMBL) vector, construct pJK23, provided by Kostan
et al. [29], was used as the starting point of this work.
The chlorite dismutase gene from N.winogradskyi (NwCld, accession no. YP_319047)
was provided as the full-length version by Stephanie Füreder and cloned into pET21b(+)
(Novagen), as well as the Cld-like genes from L.monocytogenes (lmo2113, accession
no.NC003210) and S.solfataricus (accession no. ACX92972.1).
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Table 10: List of all constructs that were used and/or created during this thesis. See the text
for details.
Construct Vector Insert Tag
pJK23 pETM-11 NdCld N-term 6x His
pJK29 pETM-11 LmCld N-term 6x His
pJK53 pETM-11 NdCld W146Y N-term 6x His
pJK53s StrepTEVpET21 NdCld W146Y N-term Strep-Tag II
pJK54 pETM-11 NdCld W145Y N-term 6x His
pJK54s StrepTEVpET21 NdCld W145Y N-termStrep-Tag II
pJK55 pETM-11 NdCld W145V W146Y N-term 6x His
pJK55s StrepTEVpET21 NdCld W145V W146Y N-term Strep-Tag II
pKG1 pETM-11 NdCld R173Q N-term 6x His
pKG1s StrepTEVpET21 NdCld R173Q N-term Strep-Tag II
pKG2 pETM-11 NdCld E210A N-term 6x His
pKG2s StrepTEVpET21 NdCld E210A N-term Strep-Tag II
pKG3 pETM-11 NdCld W146Y R173Q N-term 6x His
pKG3s StrepTEVpET21 NdCld W146Y R173Q N-term Strep-Tag II
pKG4 StrepTEVpET21 LmCld N-term Strep-Tag II
pKG5 pETM-11 NdCld E210A N-term 6x His
pKG5s StrepTEVpET21 NdCld E210A N-term Strep-Tag II
pKG6 StrepTEVpET21 NdCld R173Q E210A N-term Strep-Tag II
pKG8 StrepTEVpET21 NdCld W145F N-term Strep-Tag II
pKG9 StrepTEVpET21 NdCld W145V R173E N-term Strep-Tag II
pKG10 StrepTEVpET21 SsCld N-term Strep-Tag II
pSF22 pET21b(+) LmCld C-term 6x His
pSF29 pET21b(+) NwCld C-term 6x His
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3.5 Heterologous Protein Expression
All proteins were expressed recombinant in E.coli expression strains, listed in Table 4.
Starter cultures were grown from a glycerol stock stored at -80◦by scratching the sur-
face of a frozen stock with a pipette tip and were inoculated in 50 ml LB medium.
Protein expression at 18◦C and 24◦C was carried out in a coolable incubator shaker
(New Brunswick Scientific), at 37◦C in a non-coolable incubator shaker (New Brunswick
Scientific). The cells were always harvested by centrifugation in 1 L centrifuge tubes
using an SLC-4000 rotor at 4◦C for 20 minutes at 4000 rpm in a coolable centrifuge
(Sorvall Evolution RC Superspeed Centrifuge). The resulting pellet was resuspended
in 10 ml of the supernatant medium, transferred to a 50 ml Falcon tube and the cells
pelleted again at 4000 g for 20 minutes at 4◦C in an Eppendorf benchtop centrifuge.
3.5.1 Cld from Candidatus Nitrospira deﬂuvii (NdCld) - wild-type and
mutants
E.coli BL21 (DE3) Tuner cells or Rosetta2 cells carrying an expression vector for a
NdCld mutant (see Table 10) were grown in 50 ml selective LB medium (pETM-11:
Kanamycin; StrepTEVpET21: Ampicilin; Rosetta2 cells: additional chloramphenicol)
at 37◦shaking overnight.
An aliquot of the dense starter culture was then used to inoculate the desired amount
of selective LB in baffled shaker flasks to a starting OD600 ≈ 0.05. The expression
cultures were grown shaking at 37◦C to a OD600 ≈ 0.8, when the temperature was
reduced to 24◦C, hemin was added at a concentration of 50 mgml (1:1000, see 3) and the
expression of Cld induced with 0.5 mM IPTG. Cld was expressed 6-8 hours and the
cells afterwards harvested by centrifugation, frozen in LN2 and stored at -80◦C.
3.5.2 Cld from Candidatus Nitrospira deﬂuvii without heme (apo-NdCld)
E.coli BL21 (DE3) Tuner cells carrying the pJK23 plasmid (NdCld wild-type) were
grown in 50 ml LB-medium supplemented with kanamycin (100 µgml ) at 37
◦C overnight.
This starter culture was used for inoculation and added to LB-Kan to a starting OD600
≈ 0.05. The cells were grown at 37 ◦C under 180 rpm agitation to an OD600 ≈ 0.8. The
protein expression was then induced with 0.5 mM IPTG and protein was expressed
for 4 hours at 37◦. This yields the maximum amount of protein, while keeping the
heme content as low as possible. The cells were harvested by centrifugation, the cell
pellets flash-frozen in LN2 and stored at -80◦C until further use.
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3.5.3 Cld from Nitrobacter winogradskyi (NwCld)
E.coli BL21 (DE3) cells carrying the pSF29 plasmid were grown in 50 ml LB-medium
supplemented with ampicilin (100 µgml ) at 37
◦overnight. 10 ml of this overnight cul-
ture were used to inoculate the expression culture consisting of LB-Amp (100 µgml ) in
baffled shaker flasks to a starting OD600 ≈ 0.05. The culture was grown at 37 ◦C in
a shaker to an OD600 ≈ 0.8. The temperature was lowered to 18◦C, hemin added
to a final concentration of 50 mgL and protein expression induced with a final IPTG
concentration of 0.5 mM.
The protein was expressed overnight ( 16 h) at a low temperature to facilitate correct
protein folding to yield as high amounts of soluble protein as possible. A large part of
NwCld was expressed insolubly as inclusion bodies, as presumably heme is required
for the protein to fold correctly and is the bottleneck. Supplementing heme and slow
expression helps to express the protein soluble, but still a large part of the protein was
found mis- or unfolded in inclusion bodies.
The cells were harvested by centrifugation, pellets flash-frozen in LN2 and stored at
-80◦C until lysis and purification.
3.6 Protein Puriﬁcation Techniques
All purification steps were carried out on ÄKTA PURIFIER systems (GE Healthcare)
at 4◦C. All colums were purchased from GE Healthcare, unless stated otherwise.
Progress of the purification was monitored by measuring absorption at λ1 = 280 nm,
λ2 = 410 nm, which corresponds to the soret peak of bound heme and λ3 = 360 nm,
corresponding to the soret peak of free heme. Extinction coefficients for A280, accord-
ing to Mlynek et al. [34] and Kostan et al. [29]:
• NdCld: e=37930 M−1cm−1; E 0.1% (= 1 gl ) = 1.382
• NwCld: e=40450 M−1cm−1; E 0.1% (= 1 gl ) = 1.984
3.6.1 Puriﬁcation of NdCld Mutants
• Lysis buffer: 50 mM HEPES-NaOH pH 7.4, 5% (v/v) Glycerol, 0.5% (v/v) Triton
X-100
• Ni-NTA Binding buffer: 20 mM HEPES-NaOH pH 7.4, 2% (v/v) Glycerol, 20
mM Imidazole
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• Ni-NTA Elution buffer: 20 mM HEPES-NaOH pH 7.4, 2% (v/v) Glycerol, 500
mM Imidazole
• StrepTrap Elution buffer: 20 mM HEPES-NaOH pH 7.4 2% (v/v) Glycerol, 2.5
mM Desthiobiotin
• StrepTrap Binding/Dialysis/SEC buffer: 20 mM HEPES-NaOH pH 7.4, 2% (v/v)
Glycerol
Cell pellets stored on -80◦C were thawed and resuspended in 35 ml Lysis buffer per L
culture. Cells were broken either by sonication (3 x 5 minutes, 3 cycles, 60% power) or
on a french press and the lysate subsequently cleared by centrifugation (SS34 rotor)
at 4◦C, 38’000 g for 25 minutes.
Ni-NTA Aﬃnity Puriﬁcation The protein was expressed with an N-terminal 6xHis-
tag, imidazole was added to the supernatant to a final concentration of 20 mM and
the supernatant subsequently loaded on a HisTrap Crude FF 5 ml or HisTrap FF 5ml
column equilibrated with Ni-NTA Binding buffer. After a 5 CV washing step with the
Ni-NTA Binding buffer, red coloured Cld was eluted with a linear imidazole gradient
over 10 CV to 500 mM imidazole. The fractions were collected, analyzed by SDS-
PAGE and pooled together.
Strep-Tactin Aﬃnity The protein was expressed with an N-terminal Strep-Tag II,
the clear supernatant was loaded on a clean StrepTrap HP column previously equi-
librated with StrepTrap Binding buffer and subsequently eluted with a step gradient
of 2.5 mM Desthiobiotin in the StrepTrap Elution buffer. After analysisby SDS-PAGE,
the fractions containing Cld were pooled together.
Tags of the affinity-purified proteins were afterwards cleaved with TEV protease. The
pooled fractions were transferred to a dialysis bag with a molecular weight cutoff
of 12’000-14’000 Da, TEV protease added at a 1:30 - 1:50 mass ratio and dialyzed
overnight at 4◦C against 1-2 l of dialysis buffer. Uncleaved protein was then removed
by another Ni-NTA or Strep-Tactin affinity purification step, respectively. Cleavage
of the tag was again verified by SDS-PAGE. In order to get the protein fully loaded
with heme, hemin (freshly prepared in 0.1 N NaOH, see Table 3) was added to the
protein solution at a molar ratio of 2:1 hemin:protein, incubated for 1-3 hour(s) on ice.
Insoluble heme was then removed by centrifugation for 30 minutes at 18000 rpm at 4
◦C.
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The protein solutions were concentrated in an Amicon Ultra centrifugal filter unit
(Milipore) with a molecular weight cutoff of 30’000 to a volume of maximum 5 ml,
(which also removes most of the remaining TEV protease in case of the Strep-Tactin
based purification) and loaded on an equilibrated Superdex 200 16/60 size exclusion
column.
Pure NdCld was further concentrated in an Amicon Ultra centrifugal filter unit to
5-10 mgml , divided to 100 µl aliquots, flash-frozen in LN2 and stored at -80
◦C.
3.6.2 Puriﬁcation of Apo-NdCld
Buﬀers
• Lysis buffer: 50 mM HEPES-NaOH pH 7.4, 5% (v/v) Glycerol, 0.5% (v/v) Triton
X-100, 20 mM Imidazole
• Ni-NTA Binding buffer: 20 mM HEPES-NaOH pH 7.4, 2% (v/v) Glycerol, 20
mM Imidazole
• Ni-NTA Elution buffer: 20 mM HEPES-NaOH pH 7.4, 2% (v/v) Glycerol, 500
mM Imidazole
• AEX Buffer 1: 20 mM HEPES-NaOH pH 7.4, 2% (v/v) Glycerol
• AEX Buffer 2: 20 mM HEPES-NaOH pH 7.4, 2% (v/v) Glycerol, 2 M NaCl
• Dialysis/SEC buffer: 20 mM HEPES-NaOH pH 7.4, 2% (v/v) Glycerol
Frozen cell pellets were thawed and resuspended in 35 ml Lysis buffer per 1 L cell
culture. The cells were broken with a french press and the lysate subsequently cleared
by centrifugation at 38’000 g for 25 minutes at 4◦C. The supernatant was subjected to
Ni-NTA affinity chromatography using a HisTrap Crude FF 5 ml or HisTrap FF 5 ml
column with a washing step of 5 CV with the Ni-NTA Binding buffer and elution with
a 10 CV linear gradient of the Ni-NTA Elution buffer to a imidazole concentration of
500 mM. The purification was inspected on a gel and the fractions containing Cld
were pooled together.
In order to cleave the His-Tag, TEV protease was added at a mass ratio of 1:40 (TEV:protein)
to the protein solution and dialyzed overnight at 4 ◦C in a 12’000-14’000 Da dialysis
bag against 1-2 l of dialysis buffer. The protein solution was then subjected to another
Ni-NTA purification step to remove uncleaved protein and TEV protease.
Apo-NdCld and fully or partially loaded NdCld were subsequently separated from
each other by AEX chromatography. Previous experiments had shown that NdCld
33
3 Materials and Methods
elutes from an AEX column in two peaks containing different ASoret:A280 ratios. The
cleaved NdCld was loaded on a 6ml ResourceQ anion exchange column equilibrated
with AEX Buffer 1 (containing no NaCl). Afterwards, a subsequent washing step with
5% AEX Buffer 2 (=100 mM NaCl) was applied to remove fully and partially heme-
loaded NdCld at a conductivity of usually ≈ 11.5 mScm . A slow linear salt gradient
ascending over 15 CV to 20% Buffer 2 (=400 mM NaCl) was then applied to elute
apo-NdCld, usually at ≈ 16 mScm .
The fractions containing apo-NdCld ( ASoretA280 ≈ 110 ) were concentrated to a volume of
maximum 10 ml in an Amicon cell with 30’000 Da cutoff and loaded on a equilibrated
Superdex 200 26/60 column via an appropriately sized loop. apo-Cld was then eluted
with 1.5 CV SEC buffer.
Pure apo-Cld was concentrated to 5-10 mgml , flash-frozen in LN2 and stored at -80
◦C.
3.6.3 NdCld with Co-Protoporphyrine IX
Protoporphyrine IX containing cobalt instead of iron as a center atom was used to
exchange the metal of NdCld by reconstituting apo-NdCld.
A solution of apo-NdCld (see 3.6.2) was incubated with a 2× molar excess of cobalt
protoporphyrine IX overnight at 4◦. Precipitated Co-protoporphyrine IX was sub-
sequently removed by centrifugation at 18000 rpm for 30 minutes at 4◦in a coolable
microcentrifuge (Eppendorf) and the supernatant concentrated in a Amicon Ultra
centrifugal filter unit (10’000 Da) to a volume of 250 µl.
The supernatant was loaded on a Superdex 200 10/300 GL analytical size exclusion
column previously equilibrated with 20 mM HEPES pH 7.4, 2% Glycerol and the
pink-coloured main peak retreaved, pooled, concentrated to 3 mgml and frozen in LN2.
The enzyme’s Soret peak shifts with bound Co-protoporphyrine IX to λmax=425 nm
compared to λmax=413 nm in wild-type NdCld with heme b bound. Incorporation of
the cobalt protoporphyrine IX was also confirmed by measuring X-ray fluorescence
on a non-diffracting crystal (data not shown).
3.6.4 Puriﬁcation of NwCld
Buﬀers
• Lysis buffer: 50 mM Tris-HCl pH 8.5, 150 mM NaCl, 5% (v/v) Glycerol, 0.5 %
(v/v) Triton X-100, 20 mM Imidazole
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• Ni-NTA Binding buffer: 50 mM Tris-HCl pH 8.5, 150 mM NaCl, 2% Glycerol, 20
mM Imidazole
• Ni-NTA Elution buffer: 50 mM Tris-HCl pH 8.5 150 mM NaCl 2% Glycerol, 500
mM Imidazole
• Dialysis / SEC buffer: 50 mM Tris-HCl pH 8.5, 150 mM NaCl, 2% Glycerol
Frozen cell pellets were thawed and resuspended in 35 ml Lysis buffer per L cell cul-
ture. Cells were broken on a french press and the lysate cleared by centrifugation at
38’000 g for 25 minutes. The cleared lysate was loaded onto an equilibrated HisTrap
Crude FF 5 ml Ni-NTA column (GE Healthcare). NwCld was eluted with a linear
gradient with the Ni-NTA Elution buffer, the fractions collected and inspected with
SDS-PAGE. The fractions containing NwCld were pooled and dialyzed overnight at
4 ◦against the dialysis buffer in a dialysis bag with a 12’000-14’000 Da molecular mass
cutoff. The dialyzed protein solution was concentrated in an Amicon Ultra centrifu-
gal filter unit to a volume of 5 ml and subsequently loaded onto an equilibrated Su-
perdex 75 16/60 column (GE Healthcare) via a 5ml loop and eluted with 1.5 CV in
a single peak. Fractions were analyzed on a gel, pooled and concentrated to 3 mgml .
Aliquots of 100 µl volume were made, flash-frozen in LN2 and stored at -80◦C.
3.7 Analytical Size Exclusion Chromatography
Pure NwCld was used for analytical size-exclusion chromatography to assay the
dimer stability with increasing ionic strength.
A frozen sample of NwCld (3 mgml ) was thawed (see 3.6.4), diluted 1:10 with either
Buffer 1 (0.1 M NaCl), Buffer 2 (0.25 M NaCl), Buffer 3 (1 M NaCl) or Buffer 4 (2 M
NaCl). The samples were incubated on ice for at least 3 hours. In the meantime, a
Superdex 75 10/300 GL analytical size exclusion column (GE Healthcare) was equili-
brated with 2 CV of the corresponding buffer. 250 µl of sample were loaded onto the
column with an adequate sample loop (250 µl) and eluted for 1.5 CV. The experiments
were carried out on an ÄKTA PURIFIER system (GE Healthcare) at 4 ◦C.
• Buffer 1: 50 mM Tris-HCl pH 8.5, 0.15 M NaCl, 2% Glycerol
• Buffer 2: 50 mM Tris-HCl pH 8.5, 0.25 M NaCl, 2% Glycerol
• Buffer 3: 50 mM Tris-HCl pH 8.5, 1 M NaCl, 2% Glycerol
• Buffer 4: 50 mM Tris-HCl pH 8.5, 2 M NaCl, 2% Glycerol
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The column was then calibrated with different molecular mass standards: RNAse A
(13.7 kDa), Carbonic Anhydrase (29 kDa) and Conalbumin (75 kDa) using the dif-
ferent NaCl concentrations. A solution containing the three reference proteins in
concentrations of 3-5 mgml was prepared and as described above, diluted with the cor-
responding buffer and incubated for 30 minutes on ice before being loaded on the
column.
Kav =
Ve −Vo
Vc −Vo (2)
Kav was calculated for every molecular mass standard using equation 2. Kav values
were plotted against the logarithm of the standard’s respective molecular mass and
fitted to a linear equation y = ax + c. The molecular mass of the protein of interest
was then determined by calculating Kav and solving the linear equation.
3.8 Crystallographic Techniques
Robotics and Materials For the setup and monitoring of crystallization trials, fol-
lowing robotics were employed: i) an Alchemist II liquid handling robot (Rigaku) for
pipetting of non-commercial optimization screens and 24-well Linbro format hang-
ing drop plates, ii) a Phoenix liquid handling system (Art Robbins Instruments) for
setting up 96-well crystallization trials, iii) a Minstrel DT imaging system (Rigaku)
equipped with the Atlantis software for automatic imaging. Images were inspected
using the CrystalTrak software (Rigaku).
For commercial screens and optimizations in 96-well format pipetted by the Phoenix
liquid handling system, 3-well IntelliPlates (Art Robbins instruments) were used. 24-
well optimizations, which were set up by hand, were performed in 24-well Linbro
format plates, pregreased (Crystalgen).
Crystals were stored in a crystallization room at either 22 ◦C or 4 ◦C.
3.8.1 Crystallization of NdCld Mutants and Apo-NdCld
NdCld mutants W145V, W146Y and W146YR173Q, concentrated and stored in their
respective SEC buffer, were crystallized in conditions with high ammonium sulfate
and low pH ranges from 3.5 - 4.5 (derived from condition 13 of JCSG+ commercial
screen, Qiagen), which is similar to the crystallization conditions of the wild-type
[29]. For cryo protection, the crystal was soaked stepiwise in the mother liquor plus
increasing concentrations (10%) of ethylene glykol, up to final 50% (v/v). If directly
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put into the final cryoprotecting solution, the crystals crack and dissolve. These three
mutants were purified using Ni-NTA affinity (see Section 3.6.1). The cryoprotectants
were freshly prepared, with the final solutions containing exactly the mother liquor
and the final concentration of cryoprotecting agent. The R173E mutant was crystal-
lized in 0.1 M sodium acetate, pH 4 and 40% (v/v) ethylene glykol (Condition 2 from
the CryoI+II screen, Emerald Biosciences) , which already served as cryoprotectant.
The protein was purified using Strep-Tactin affinity.
Apo-NdCld crystallizes in half of the conditions of the PACT I+II screen (Qiagen), for
the best condition see Table 11.
Table 11: Crystallization conditions of the different NdCld mutants. Drop ratio specifies the
ratio of protein:precipitant solution in absolute volumes in µl.
Mutant Condition Drop [µl] Cryoprotectant
W145V 10 mgml protein, 0.1 M cit-
ric acid pH 4.0, 1 M
(NH4)2SO4, 22◦C
2:1, hanging 50% (v/v) ethy-
lene glycol
W146Y 10-11 mgml protein, 0.1 M
citric acid pH 4.0, 0.8 M
(NH4)2SO4, 22◦C
2:1, hanging 50% (v/v) ethy-
lene glycol
W146Y
R173Q
10 mgml protein, 0.1 M cit-
ric acid pH 3.5, 0.8 M
(NH4)2SO4, 22◦C
1:1, hanging 50% (v/v) ethy-
lene glycol
R173E 0.1 M NaAc pH 4.5, 40
% (v/v) ethylene glycol,
4◦C
0.3:0.1, sitting None
Apo 10 mgml protein, 0.1 M bis-
tris propane pH 6.5, 20%
(w/v) PEG 3350, 0.2 M
NaAc, 22◦C
0.3:0.1, sitting 35% (w/v) PEG
3350
3.9 Structure Determination and Reﬁnement Techniques
3.9.1 Data Collection and Processing
Diffraction data were collected either in-house on a Bruker Microstar (Bruker AXS
Inc.) rotating anode at 1.54 Å wavelength or at several ESRF beamlines (ID14.4, ID23,
ID29, BM14U). Details are presented in Tables 12, 13, 16. Integration and scaling was
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done with XDS and XSCALE [27], except for the data collected in-house, which was
processed with the software Proteum2 (Bruker AXS Inc.).
Valid for all following tables and data collection statistics, unless stated otherwise:
Rmeas =
∑hkl
[ N
N−1
] 1
2 ∑i |Ii(hkl)− 〈I(hkl)〉|
∑hkl ∑i Ii(hkl)
(3)
Rmerge =
∑hkl ∑i |Ihkl − 〈I(hkl)〉|
∑hkl ∑i Ii(hkl)
(4)
Where in equations 3 and 4 Ii(hkl) and 〈I(hkl)〉 are the ith and the mean measure-
ments of the intensity of reflection hkl and N is the redundancy.
3.9.2 Molecular Replacement, Model Building and Reﬁnement
All structures were solved by molecular replacement using the program MOLREP
[50] with chain A from the wild-type NdCld structure (3NN1, [29]). Subsequent
refinement was performed with phenix.refine from the PHENIX suite [1] and coot
[14]. The overall structure quality was judged with the web server Molprobity [11].
NCS, secondary structure and ramachandran restraints were utilized during refine-
ment, as well as a stepwise adjustion of X-ray/geometry (wxc_scale) and X-ray/ADP
(wxu_scale) weight scale factors.
Valid for all following refinement statistics:
Rwork =
∑ |Fo − Fc|
∑ Fo
(5)
R f ree is the cross-validation R f actor computed for the test set of reflections (5%) which
are omitted in the refinement process.
Visualizations of molecular models were generated in PyMOL (http://www.pymol.org).
3.10 Enzymatic Activity Techniques
3.10.1 Steady-state Kinetics
The activity of NdCld mutants was determined by quantifying the release of oxygen
when the enzyme is processing its substrate, ClO−2 . This was measured with a Clark-
type electrode (Oxygraph System, Hansatech Instruments, Norfolk, UK) in a stirred
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water bath at a constant temperature of 30◦C. Measurements were done in 100 mM
phosphate buffer, pH 7.0. The electrode was equilibrated to 100% O2 saturation by
bubbling O2 to a blank reaction mixture for 10 minutes and with 0% O2 by bubbling
with N2 for another 10 minutes, thus purging all oxygen.
For activity measurements the substrate was added to the cell in increasing concen-
trations of 25-1000 µM ClO−2 . The buffer-substrate solution (total volume of 1.95 ml)
was purged from all oxygen by bubbling the solution with N2 until a stable base-
line was reached. Subsequently the reaction was initiated by injecting 50 µl of a 2µM
NdCld solution into the cell with a hamilton syringe to a final concentration of 100
nM.
Only the initial linear rate was used to calculate the reaction rate. Molecular oxygen
production rates (µM O2s−1) were determined and plotted against chlorite concen-
trations in SigmaPlot (Systat Software Inc., v12). The Michaelis-Menten equation was
utilized for fitting and calculating the values of the kinetic constants of the enzyme:
KM, the Michaelis constant - KM=Vmax2 (µM); kcat, the turnover number (s
−1) and kcatKM ,
the catalytic efficiency of the enzyme.
3.11 Biophysical characterizations
3.11.1 Static Light Scattering
The biophysical technique of static light scattering can be used experimentally deter-
mine the molecular mass (Mw), radius of gyration of the molecule, and second virial
coefficient (A2) [35]. Here it was used to assay the molecular mass of different chlorite
dismutases in solution, thus yielding information about their oligomeric state.
A miniDawn Treos (Wyatt) light scattering detection system connected to an RI-101
refractometer (MD Scientific) and an Agilent 1260 Infinity HPLC with a Superdex
200 10/300 GL analytical size exclusion column (GE Healthcare) was equilibrated
overnight with the respective protein SEC buffer, unless stated otherwise, until a sta-
ble baseline was reached. The protein solution was either dialyzed overnight against
this buffer or the protein buffer exchanged against this buffer on a spin column (Bio-
Rad) immediately before the experiment. 100 µl of a 1 mgml protein solution were
loaded to the system described above with the autosampler. The protein peak was
identified with A280 and correlated to the molecular mass determined by static light
scattering at the given retention volume.
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4.1 Structural Studies of NdCld Mutants
The NdCld mutants W145V (pJK54), W146Y (pJK53), W146Y R173Q (pKG3) and
R173E (pKG5s) were crystallized (see Figure 11, 12 and 13) and their three-dimensional
structure determined by X-ray diffraction. The proteins were expressed and purified
using the methods described in 3.5.1 and 3.6.1. Crystallization procedures and condi-
tions are described in 3.9. Interestingly, the achieved resolution did never exceed 2.8
Å, despite testing different crystal types. Similarly, the structure of two other mutant
versions of NdCld (R173A and R173K) was determined to the resolution of 2.8 Å,
while the wild-type NdCld structure was solved at a resolution of 1.8 Å. Therefore,
it can be assumed that the introduced active site point mutations give a number of
residues in the active site additional flexibility, leading to less ordered crystals and
consequently to diffraction to lower resolution.
Figure 11: Crystals of NdCld mutant W146Y. The scalebar indicates a size of 1 mm.
While the proteins purified by Ni-NTA affinity (mutants W145V, W146Y, W146Y R173Q)
crystallized in conditions similar to the wild-type, the R173E mutant instead crystal-
lized in the very different condition 2 of the CryoI+II screen (0.1 M sodium acetate
pH 4.5, 40% (v/v) ethylene glycol, 4◦C). Most likely the different protein purification
approaches without an inhibitor affect the crystallization behaviour of NdCld. Nev-
ertheless, crystallization of R173E was successful at a pH of 4.5, the low pH being a
common factor for all crystallization conditions.
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Figure 12: Crystals of NdCld mutants W146Y R173Q (left) and W145V (right). The scalebars
indicate a size of 1 mm.
Data collection and refinement statistics are displayed in Tables 12 and 13. Inter-
estingly, while wild-type and mutants where R173 is not changed to another amino
acid, always crystallize in the primitive hexagonal spacegroup P3221. As soon as
the residue Arg 173 is mutated, or the heme is missing (see section 21), the crys-
tal packing changes and with it the spacegroup to the base-centered orthorhombic
spacegroup C2. This was already noticed by Kostan et al. [29] and further confirmed
here. Despite the mutant structures being highly similar to the wild-type (the maxi-
mum r.m.s.d. is 0.8 Å, for details see the respective section), the change of one single
residue is sufficient to change crystal packing completely.
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Table 12: Data collection and refinement statistics for NdCld mutants W145V and W146Y.
Mutant W145V W146Y
Source home source home source
Wavelength (Å) 1.54 1.54
Spacegroup P3221 P3221
Unit cell a=145.83, b=145.83, c=137.22 a=145.89, b=145.89, c=135.38
Temperature (K) 100 100
Molecules a.u. 5 5
Unique reflections 41972(4187) 39319(3837)
Resolution 66.80-2.80(2.90-2.80) 73.93-2.85(2.95-2.85)
Completeness 99.1(99.9) 100.0 (100.0)
Redundancy 35.4(21.74) 38.3(27.60)
I/σ(I) 23.3(2.10) 32.2(4.80)
Rmerge 0.16(0.72) 0.12 (0.47)
Rwork 0.248 0.232
R f ree 0.309 0.282
RMSD, bonds (Å) 0.016 0.013
RMSD, angles (◦) 0.682 1.508
Avg. B-factor (Å2) 80.7 61.02
Residues modeled 1195 1195
Waters 159 122
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Table 13: Data collection and refinement statistics for NdCld mutants R173E and W146Y
R173Q
Mutant R173E W146Y R173Q
Source BM14-U ID23-1
Wavelength (Å) 0.976 0.667
Spacegroup C2 C2
Unit cell a=138.26 b=111.95 c=120.29
β=118.6
a=138.22 b=114.93 c=118.90
β=118.1
Temperature (K) 100 100
Molecules a.u. 5 5
Unique reflections 37433(2768) 35640(2627)
Resolution (2.92-2.85) 44.39-2.90(2.98-2.90)
Completeness 99.6(99.1) 98.9(98.6)
Redundancy 4.01(6.07) 3.7(6.03)
I/σ(I) 8.52(1.93) 9.3(2.28)
Rmerge 0.179(0.958) 0.145(0.853)
Rmeas 0.206(1.047) 0.168(0.934)
Rwork 0.217 0.230
R f ree 0.282 0.290
RMSD, bonds (Å) 0.006 0.006
RMSD, angles (◦) 0.965 1.051
Avg. B-factor (Å2) 72.9 80.7
Residues modeled 1195 1195
Waters 165 15
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Figure 13: Crystal of NdCld mutant R173E in a nylon loop mounted on ESRF beamline
BM14U. The scalebars indicate a size of 0.1 mm.
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4.1.1 Structure of the W145V mutant in Complex with Imidazole
The W145V mutant was designed with the rationale to assay the side pathway de-
scribed in section 1.6 involving the formation of a tryptophanyl radical, proposed to
lead ultimately to heme bleaching. Its structure was solved at a resolution of 2.80 Å.
Data collection and refinement statistics are listed in Table 12. It is highly similar to
the wild-type, with a r.m.s.d. over all subunits of 0.55 Å over 1185 Cα-atoms (out of
1190) and an r.m.s.d. of 0.40 Å over 238 out of 238 Cα-atoms. Figure 14 displays the
active site structure of the mutant (Panel A) and superimposed with the wild-type
structure of NdCld (Panel B). Trp 145 is conserved throughout all CFPs (see Table
1). Replacement of the large aromatic tryptophan side chain with a valine yields a
cavity, which is filled with a sulfate with variable occupancy in the 5 subunits. The
juxtaposed Trp 146, oriented orthogonally to Trp 145 in the wild-type structure tilts,
with its χ-angle differing by 20◦compared to the wild-type structure. The other active
site residues retain their conformations with the exception of the proximal H-bonding
network triad, which seems to be destabilized because of the missing Trp 145 and the
presence of SO−2 . Lys 141 seems to form H-bonds with a water molecule, as could
Glu 210. Either of this interactions is likely to have a destabilizing effect on the prox-
imal triad. Furthermore, the position of the tetrahedral ion (PO3−4 in the wild-type,
SO2−4 in W145V, both originating from the respective precipitant solution) moves to
the cavity opened by the missing aromatic side chain, possibly also influencing the
orientation of Glu 210.
Figure 14: Active site structure of NdCld single mutant W145V (Panel A), overlay with active
site structure of wild-type NdCld (Panel B).
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4.1.2 Structure of the W146Y Mutant in Complex with Imidazole
The second of the juxtaposed orthogonal tryptophans, Trp 146 was changed to a ty-
rosine residue due to its status as a proposed signature residue (see Table 1). In many
Cld-like CFPs, e.g. LmCld, the corresponding residue to Trp 146 is a tyrosine. The
active site structure of this mutant and the overlay with the wild-type are depicted in
Figure 15. The r.m.s.d. between the mutant pentamer and the wild-type is 0.50 Å over
1183 Cα-atoms (out of 1190), single subunits overlay with an r.m.s.d. of 0.30 Å over
238 Cα-atoms (out of 238), the mutant structure therefore being only marginally dif-
ferent from the wild-type structure. The active site structure of this mutant in the re-
veals no further effect on the other signature residues except the obvious replacement
of tryptophan with a tyrosine residue. The position of the tetrahedral ion located be-
tween residue 146 and the propionate group of the heme is also well-preserved here.
Instead of two cryoprotecting ethylene glycol molecules in the vicinity of the heme,
another SO2−4 ion is present in the W146Y mutant.
Figure 15: Active site structures of NdCld single mutant W146Y (Panel A), overlay with active
site structure of wild-type NdCld (Panel B).
4.1.3 Structure of the R173E Mutant in Complex with Acetate
Arg 173 was already shown to be a crucial residue for the mechanism of chlorite
degradation [29], the structures of two Arg 173 mutants, R173A and R173K were
already solved previously. Figure 16 shows the active site structure of the R173E
mutant which was designed to see the effect of a switched charge on the reaction and
the structure. Also in this mutant, the overall fold is well-preserved with an r.m.s.d.
of 0.40 Å over 1033 cα-atoms (out of 1190) and an r.m.s.d. of 0.41 Å over 234 out of 238
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residues when superposing the single subunits. A distal axial ligand of iron, which is
too large for water is found in the electron density. Because the protein was purified
and crystallized without the use of imidazole, this ligand is most likely acetate, being
present in the crystallization solution. The glutamate side chain is smaller than the
arginine, but its charge is similarly oriented away from the active site. Leu 168 shifts
towards Glu 173, filling the cavity occupied in the wild-type by the guanidinium
group of Arg 173.
Figure 16: Active site structure of NdCld mutant R173E (Panel A) in complex with acetate,
Overlay with active site structure of wild-type NdCld (Panel B) in complex with
imidazole.
4.1.4 Structure of the W146Y R173Q Double Mutant in Complex with
Imidazole
The double mutant W146Y R173Q was designed to mimick the active site of Cld-
like CFPs, e.g. LmCld. As in the W146Y single mutant, the electron density for a
tyrosine side chain is recognizable, but apart from that there are no structural effects
on the rest of the active site (Figure 17) Gln 173 is shorter than Arg, but has the same
orientation, facing away from the active site. The small cavity formed by the absence
of the guanidinium group leads here to a slight change of position of the adjacent Leu
168, pointing now slightly more towards the heme inside the cavity, resembling the
R173E mutant (see Figure 16) The structure of a single subunit of the double mutant
is also highly similar to the wild-type with an r.m.s.d. of 0.32 Å over 218 Cα-atoms
(out of 238), the pentamers superpose with an r.m.s.d. of 0.80 Å over 1183 residues
(out of 1190).
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Figure 17: Active site structure of NdCld double mutant W146Y R173Q (Panel A) in complex
with imidazole. Overlay with active site structure of wild-type NdCld (Panel B),
also in complex with imidazole.
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4.2 Steady-state Kinetics of NdCld, Mutants and Variants
Steady-state kinetics were measured for NdCld wild-type, single and double mu-
tants of described signature residues and of the cobalt protoporphyrine IX - binding
variant. As imidazole is a known weak inhibitor of heme binding proteins [29, 39],
and we also see imidazole in the active site as distal axial ligand of the iron in crystal
structures of NdCld purified by Ni-NTA affinity purification. Additionally, imidazole
binding to the heme iron was also observed by UV-VIS spectroscopy, as displayed in
Figure 18. Upon addition of imidazole, the soret band of the wild-type NdCld shifts
from λmax=408 nm to the right, with λmax=413 nm. For comparison, binding of the
irreversible inhibitor CN− shifts the soret band to λmax=425 nm. Data in Figure 18
is shown for the wild-type NdCld, each mutant has a different λmax, which are dis-
played in Table 14.
Table 14: UV-VIS spectral characterization of NdCld wild-type and mutants. The proteins
were expressed without imidazole. The column on the far right is ASoretA280 , the Rein-
heitszahl (RZ) of the protein. The low RZ of W145V is surprising, as the crystal
structure exhibited a completely occupied molecule.
Protein Soret [nm] ASoretA280
wildtype 408 2.1
K141E 410 2.9
W145V 412 1.3
W146Y 413 2.1
R173A 412 0.5
R173K 412 1.2
R173E 411 1.8
R173Q 406 1.4
E210A 412 1.8
W145V W146Y 408 2.5
W146Y R173Q 409 1.8
R173Q E210A 405 0.9
Therefore, Ni-NTA affinity purification, which relies on the displacement of a poly-
histidine tag from a Ni+-charged resin with high concentrations of imidazole, was
avoided for isolation of proteins required for measurements of steady-state kinetics.
Instead, the purified proteins utilized for kinetic measurements were expressed as
fusion proteins with a cleavable N-terminal Strep-Tag II, which was removed by TEV
protease during purification. Strep-Tag based affinity purification relies on elution
with desthiobiotin [37], thus allowing purification of NdCld without imidazole.
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Table 15: Steady-state kinetics for molecular oxygen evolution of NdCld wild-type, mutants
and variants. Values for Km and kcat were determined by measuring the initial linear
rates of oxygen evolution with a Clark-type electrode from 25 µM to 1 mM substrate
concentration and fitting the Michaelis-Menten equation. All mutated residues are
located in the enzyme’s active site, compare Figure 8. Values from Kostan et al. [29]
and van Ginkel et al. [52] are listed for direct comparison with a) the previous work
on NdCld and b) a Cld from a PCRB.
Protein KM [µM] Kcat [s−1] KcatKM [M
−1 s−1] Notes
NdCld (wt) 58±37 35 6.0×105 Kostan et al. [29],
+ imidazole
NdCld (wt) 52±7 42 8.1×105
NdCld K141E 60 ±11 1.8 3.0×104
NdCld W145V 103±11 14 1.4×105
NdCld W146Y 87±8 36 4.1×105
NdCld R173A 107±54 7.1 6.6×104 Kostan et al. [29],
+ imidazole
NdCld R173A 90 ±9 2.8 3.1×104
NdCld R173K 818±250 21 2.5×104 Kostan et al. [29],
+ imidazole
NdCld R173K 898±250 14 1.5×104
NdCld R173E 82±4 3 3.6×104
NdCld R173Q 130 ±7 2.3 1.8×104
NdCld E210A 128±15 36 4.1×105
NdCld W145VW146Y 76±7 2.9 3.8×104
NdCld W146YR173Q 205±18 4.1 2.0×104
NdCld E210AR173Q 184±36 0.85 4.6×103
Cobalt-NdCld 763±109 11.3 1.4×104
Azospira oryzae 170 1200 7.1×106 van Ginkel et al.
[52], Strain GR-1
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Table 15 shows a summary of the kinetics with the measured kinetic parameters,
which are KM, kcat and kcatKM . Comparable to the wild-type and the previously mea-
sured mutants of NdCld and the NwCld wild-type [29, 34], the steady-state data
could be fitted best with a double rectangular hyperbola equation. Enzyme kinet-
ics were only measured up to a ClO−2 concentration < 1mM, which corresponds to
natural conditions.
In principle, all mutations, single and double, were detrimental for the activity of
NdCld, with KM concentrations increasing and kcat rates decreasing, leading to an
overall reduced catalytic efficiency kcatKM . The contributions of KM and kcat to the cat-
alytic efficiency vary, though.
An overview is displayed in Figure 19, which presents an overall evaluation of the
respective ability of the mutants to bind and process substrate. In order to analyze
the effect of a mutation of an active site residue it is necessary to evaluate KM and
kcat separately. Mutants with a higher KM than the wild-type are deficient in forma-
tion of the Michaelis complex ES, mutants with lower kcat are deficient in catalyzing
the reaction, metabolizing less substrate in the same timespan. Figure 20 displays
both values separately, thus enabling evaluation of the contribution of each residue
to substrate binding or to the turnover rate, respectively.
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Figure 18: Panel A: Comparison of NdCld UV-VIS spectra upon addition of inhibitors. Blue:
0.3 mgml NdCld without imidazole. λmax = 408 nm. Red: NdCld + 2 mM imidazole.
λmax = 413 nm. Yellow: NdCld with 2 mM CN− and 2 mM imidazole. λmax = 421
nm. Green: NdCld with 2 mM CN−. λmax = 421 nm.
Panel B: UV-VIS spectra of NdCld variants. Red: 0.3 mgml Fe-NdCld without
imidazole.λmax = 408. Yellow: 0.3
mg
ml NdCld + 2 mM imidazole. λmax = 413 nm.
Blue: 0.3 mgml Cobalt-NdCld. λmax = 425 nm.
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Figure 19: The catalytic efficiency kcatKM of NdCld mutants plotted on a logarithmic scale.
WT(2010) represents the value published by Kostan et al. [29] for comparison.
Figure 20: KM and kcat values of NdCld mutants compared. WT(2010) represents the value
published by Kostan et al. [29] for comparison.
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4.3 Structure of apo-NdCld
Apo-NdCld was crystallized in 0.2 M sodium acetate, 20% (w/v) PEG 3350, 0.1 M
bis-tris propane pH 6.5, which is condition 67 from the PACT I+II commercial screen
(Qiagen). Crystals were found in over 50% of the condition of the PACT I+II screen,
but this condition yielded large single crystals (Figure 21), which diffracted best. Sim-
ilarly to the structures of the NdCld mutants, the dataset was collected to 2.9 Å, in-
dicating that increased flexibility of residues binding to heme in the holo-form of the
enzyme affects the diffraction ability of the crystals. Unlike the holo-enzyme, which
crystallized in the hexagonal primitive spacegroup P3221, apo-NdCld crystallized in
the monoclinic base-centered spacegroup C2, similar to all Arg 173 mutants. The data
collection and refinement statistics are displayed in Table 16.
Figure 21: Crystals of apo-NdCld after 2 days. The scalebar indicates a size of 1 mm.
Surprisingly, the oligomeric state of apo-NdCld in the crystal was found to be hex-
americ, not pentameric as seen in the wild-type (Figure 22). The molecular mass of
apo-NdCld was determined in solution with static light scattering and was found to
be a pentamer, having roughly the same size as the fully loaded active form. There-
fore the hexameric structure is a crystallographic artifact, maybe originating from the
slight conformational changes that differentiate holo-NdCld and apo-NdCld. Figure
24 shows the SLS data. Analysis of the hexameric X-ray structure by PISA [30] sug-
gests that the hexamer has no specific or too weak interactions which could result in
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Figure 22: Top view of the structure of hexameric apo-NdCld in cartoon representation.
the formation of a stable quarternary structure in solution.
The structures of one subunit of apo-NdCld and holo-NdCld are very similar, with
a root mean square deviation of 0.490 Å over 196 Cα atoms (out of 216) (see Figure
23). An exception is the region over the heme-binding cavity that is formed by the
residues 107 - 130 (comprising α6 of the N-terminal and α1’ of the C-terminal domain),
which is disordered in all six monomers in the crystal structure of apo-NdCld and is
likely to be flexible in solution as well. Therefore, in apo-NdCld, 216 instead of 238
residues (holo-NdCld) could be modeled (see Figure 23).
After incubation of apo-NdCld with hemin, binding of heme was observed that re-
stored the enzyme to an active state (see 3.6.2), resulting in the stabilization of this re-
gion. In the structure of the holo-enzyme and the mutant versions with bound heme,
there is visible electron density for the region from residue 107-130. In the structure
of the Cld-like homolog from Listeria monocytogenes, where no heme density is visible,
the structurally similar part of this protein is as well flexible, having no interpretable
electron density (Mlynek et al, unpublished data).
As α6 and α1’ are directly interacting with the heme in NdCld, it is likely for this part
of the protein to become disordered in the absence of heme. The rest of the C-terminal
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Figure 23: Comparison of apo-NdCld (left) and holo-NdCld with coloured secondary struc-
ture elements: α-helices in red, β-strands in yellow and loops in green. The region
from residue 107-130 is disordered in apo-NdCld and could not be modeled.
ferredoxin fold is rather well-ordered, with the exception for helix α3’, which is also
directly involved in heme binding. α3’ is still visible and tracable in the electron
density, but less defined than the rest of the molecule.
Some differences are in side chains of the active site residues; Figure 25 shows an
overlay of the important active site residues in stereo view. The role of Leu 168
in heme stabilization and determining the size of the heme cavity, as suggested by
Mlynek et al. [34], is emphasized by the side chain becoming flexible, the visible den-
sity pointing into the cavity of protein without heme present. The conformation of
Ile 138, which is the other residue that restrains the cavity, is not affected whether
heme is present or not. When lacking the hydrogen bond to the heme’s propionate
group, Trp 145 becomes destabilized. In 4 of 6 subunits Trp 145 flips and takes the
conformation visible in Figure 25. Density of Arg 173 is not very clear, especially the
guanidinium group lacking clear density. Nevertheless it can be seen, that the side
chain seems to point in direction of His 160 and not to the side as in the holo-form,
indicating possible hydrogen bonding with His 160.
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Figure 24: SLS experiment with apo-NdCld. The molecular mass at the peak was determined
to be 135 kDa, corresponding to 5.0 monomers of apo-NdCld.
Figure 25: Stereo view of the holo-NdCld and the apo-NdCld active site. Differences in side
chain positioning are clearly visible. Leu 168 becomes more flexible without bound
heme, Arg 173 becomes flexible and seems in some subunits to hydrogen bond to
His 160. Lacking the hydrogen bond to the heme’s propionate group, Trp 145 is
lacks stability and flips in half of the subunits. Residues 107-112 are omitted from
the cartoon representation.
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Table 16: Data collection and refinement statistics of apo-NdCld.
apo-NdCld Statistics
Data collection statistics
Source ID14-4 (ESRF)
Wavelength (Å) 0.939
Spacegroup C2
Unit cell (Å, ◦) a=115.84 b=118.96 c=114.94 β=109.9
Temperature (K) 100
Molecules a.u. 6
Unique Reflections 63699(10172)
Resolution (Å) 41.18-2.90 (2.98-2.90)
Completeness 99.5 (99.8)
Multiplicity 2.09 (2.1)
I/σ(I) 14.38 (2.56)
Rmerge 0.044 (0.437)
Rmeas 0.060 (0.584)
Rwork 0.187
R f ree 0.256
RMSD, bonds (Å) 0.004
RMSD, angles (◦) 0.900
Avg. B-factor (Å2 81.1
Residues modeled 1300
Waters 5
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4.4 Stability of the NwCld Dimer
The stability of the NwCld dimer was assayed by analytical size exclusion chromatog-
raphy as described in 3.7 in function of increasing ionic strength ranging from 0.1 M
NaCl to 2 M NaCl. The primary sequence of NwCld is about 30% shorter than the
confirmed Clds, with the large α-helical part of the N-terminal region (α1-α5, α6’)
missing. The C-terminal domain with the heme-binding active site is highly similar
to the canonical Clds.
The interface between the two subunits in NwCld was predicted by the PISA server
[30] to be mostly of electrostatic and to a less extent of hydrophobic nature [34]. Sub-
jecting the protein to increasing ionic strength was assumed to break these interaction
and to yield a monomeric protein population. Figure 26 shows the elution profiles of
NwCld under increasing salt conditions, traced by OD280, Table 17 shows the cor-
responding data. Interestingly, the protein seems continues to be stable up to the
highest salt concentrations used (2 M NaCl). Furthermore, no protein was eluted at
the void volume, an indication of aggregation. Instead, NwCld elutes as a single
peak at all salt concentrations. Additionally, a static light scattering experiment was
performed as described in Section 3.11.1 in a 20 mM HEPES, 2% glycerol buffer, con-
taining no additional salts contributing to ionic strength. Here, the protein was also
shown to be a dimer, having a molecular mass of approx. 45 kDa.
These results were published in Mlynek et al. [34].
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Table 17: Analytical SEC experiments with increasing ionic strength. The calculated molecu-
lar mass of the NwCld protein is shown.
Protein Mw [kDa] log MW Kav Retention volume [ml]
0.1 M NaCl
Conalbumin 75 1.88 0.21 11.33
Carbonic Anhydrase 29 1.46 0.38 13.89
RNAse A 13.7 1.14 0.49 15.61
NwCld (experimental) 45.58 1.66 0.26 11.98
0.25 M NaCl
Conalbumin 75 1.88 0.22 11.33
Carbonic Anhydrase 29 1.46 0.39 13.89
RNAse A 13.7 1.14 0.50 15.61
NwCld (experimental) 44.80 1.66 0.31 12.21
1 M NaCl
Conalbumin 75 1.88 0.22 11.46
Carbonic Anhydrase 29 1.46 0.39 14.00
RNAse A 13.7 1.14 0.50 15.85
NdCld (experimental) 48.05 1.68 0.31 12.56
2 M NaCl
Conalbumin 75 1.88 0.22 11.42
Carbonic Anhydrase 29 1.46 0.38 13.97
RNase A 13.7 1.14 0.51 16.02
NwCld (experimental) 47.72 1.68 0.31 12.74
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Figure 26: Elution profile (A280) of NwCld subjected to increasing ionic strength. The arrows
indicate the elution of the hypothetical NwCld monomer. 250 µl sample were ap-
plied via a 250 µl sample loop onto a Superdex 75 10/300 GL analytical size ex-
clusion column (GE Healthcare) on an ÄKTA PURIFIER system with a flowrate of
0.8 mlmin . The main and only peak shows always the dimeric NwCld, also there is
no peak visible in the void volume, which would indicate denaturation and subse-
quent aggregation of the protein upon high ionic strengths.
62
4 Results
Figure 27: SLS experiment with 1 mgml pure NwCld in 20 mM HEPES pH 7.4, 2% glycerol.
The protein elutes as a single peak and has a molecular mass of approx. 45 kDa,
therefore being a dimer also in solution.
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5.1 Arginine 173 Mutations have Severe Eﬀects on the
Enzymatic Activity
We investigated the structure of one single and one double catalytic arginine mu-
tant of NdCld (R173E, W146Y R173Q) and determined the steady-state kinetics of
four arginine single and double mutants (R173Q, R173E, W146Y R173Q and R173Q
E210A), extending the study done by Kostan et al. [29] on the R173K and the R173A
single mutants, which were characterized functionally and structurally. Our results
underline that Arg 173 is a critical residue for the reaction mechanism of chlorite
degradation. The catalytic efficiency is in all single arginine mutants reduced by one
order of magnitude compared to the wild-type. The value for the double mutant
R173Q E210A decreases by two orders of magnitude to a value of 4.6×103 M−1s−1
and is therefore the mutant with the lowest activity.
Our data confirm that the catalytic arginine in chlorite dismutases is not required
for substrate binding to the heme iron, yielding the Michaelis complex, but that the
presence of arginine is involved in the various stages of the reaction, especially in
positioning and stabilizing the intermediate hypochlorite.
The R173K mutant, described by Kostan et al. [29] is the only arginine mutant until
now where substrate binding is severely impaired and therefore the formation of
the Michaelis complex is hindered. The structure of this mutant illustrated that the
lysine forms a hydrogen bond to a sulfate molecule which is located close to the active
site. The lysine is therefore stabilized in this conformation and hinders substrate
accessibility to the site of the reaction [29]. Due to its positive charge it is able to
understudy for the catalytic arginine in stabilization of the substrate.
The R173E mutant, which was produced and functionally and structurally charac-
terized in this thesis, does hardly interfere with initial formation of the Michaelis
complex, exhibiting a KM value (82±4 µM) closely resembling the wild-type NdCld.
It can be suggested that the opposite charge of this mutant therefore does not repulse
the substrate, which carries a negative charge as well.
In the structure of the wild-type, the side chain of the catalytic arginine points away
from the iron in the direction of the Leu 168 residue (see Figure 8). This orientation is
conserved for the different side chains in the other arginine mutant structures, except
for R173A and the previously described R173K mutant. A negative charge, as present
in the sidechain of the R173E mutant is therefore unlikely to lead to initial substrate
repulsion.
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The glutamine side chain of the R173Q mutant is also not able to rescue the reaction.
It might not be able to stabilize the intermediate ClO− to the extent of lysine due
to the missing charge of the amide group and the shorter length of the glutamine
compared to arginine or lysine. The carbonyl group of glutamine could additionally
disturb stabilization of the intermediate due to sterical hindrance.
All arginine mutants - except for R173K - have significantly reduced turnover rates
15, as much as fifty times lower compared to the wild-type. This supports the model
that the positive charge is indispensable for correct positioning and orientation of
the reaction intermediate, as suggested by Mlynek et al. [34]. Our data confirm this
hypothesis. The mutants with negatively charged side chains are not able to stabilize
or even repulse intermediate ClO− during the reaction.
Taken together data underline the importance of the catalytic arginine for the chlorite
dismutase reaction [29]; they confirm that the nature of this residue is one of the most
important parameters when looking for active chlorite dismutases on a sequence ba-
sis. All hitherto validated chlorite dismutases of both Lineage I and II have the argi-
nine in the active site [17, 34]; the R173Q mutant mimicks the ”glutamine“ cluster in
CFPs (see Section 1.3). The reduced activity of this mutant suggests that these pro-
teins are likely to be ”bad chlorite degraders” - if at all. They might have a different,
yet unknown function, which is likely to be more ancient. The lack of structural in-
formations about the reaction mechanism leaves the exact process, how the catalytic
arginine performs its essential task, yet unanswered. Due to the contribution of the
catalytic arginine in stabilizing reaction intermediates with its charge, the side chain
needs to possess an innate flexibility enabling it during the reaction cycle to adopt
a conformation similar to the R173K mutant [29] or to the corresponding residue in
AoCld [12].
5.2 Investigation of Additional Signature Residues
Several NdCld mutants were designed to address the subject of the signature residues
for active chlorite dismutases proposed by Mlynek et al. [34] and Goblirsch et al. [17]
besides the already confirmed Arg 173.
The proximal His-Glu-Lys triad, consisting in NdCld of His 160, Glu 210 and Lys 141
was proposed to increase the imidazolic character of the proximal histidine, which
coordinates the heme iron (His 160), therefore influencing its redox potential [29].
Based on the structure of wild-type NdCld, Glu 210 forms a hydrogen bond from
Lys 141. This positions its carboxyl group of adequately to accept another hydrogen
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bond from the Nδ of His 160, which in turn renders N of His 160 more able to co-
ordinate Fe3+. We produced the mutants K141E and E210A with the goal to disturb
this hydrogen bonding network and measured steady-state kinetics of them to see
the contribution of these residues to substrate binding and turnover rate. Both mu-
tants had a relatively mild effect on substrate binding, especially the K141E having
approximately the same KM as the wild-type. Turnover rates were reduced to 25%
of the wild-type kcat in case of E210A and to 5% for K141E. The proposed role of Lys
141 is the stabilization of the H-bonded glutamate side chain in its unusual rotamer
conformation in order to facilitate its H-bonding to the proximal histidine. Reversing
the charge of Lys 141 is likely to lead to charge repulsion of the adjacent glutamate,
which in turn affects the orientation of the juxtaposed proximal histidine more than
exchanging Glu 210 to the small, nonpolar alanine.
The structural data (see Figure 14) support the measured steady-state parameters.
While the W146Y mutant is structurally unobtrusive, the W145V mutant shows al-
terations in both the positioning of the neighbouring Trp 146 and the proximal triad.
Hence, the W145V mutant shows similar effects to mutants E210A and K141E, pos-
sibly through affecting the hydrogen bonding network visible in the structure, sta-
bilizing the His-Glu-Lys triad. Furthermore, the H-bond between Trp 145 and the
propionate group of the heme is interrupted in the W145V mutant. Comparison of
NdCld wild-type and of this mutant structures shows that Trp 145 stabilizes the ori-
entation of the adjacent Trp 146.
Mutations of the two vicinal tryptophan residues Trp 145 and Trp 146 did not yield
information about the formation of a tryptophanyl radical. Measuring steady-state
kinetics cannot answer the question whether and how this side path of the chlorite
degradation reaction is affected by mutating the two tryptophans and which trypto-
phan is involved, because heme bleaching and enzyme inactivation is not captured
in this experiments. Further studies on this mutants and the double mutant W145V
W146Y and the new single mutant W145F will address this question.
It can be concluded that the mechanism of chlorite dismutation depends on many
active site residues which are involved in a complex interplay. Our mutational stud-
ies suggest immediate effects of Glu 210 and Lys 141, the residues of the proximal
triad on the reaction mechanism. While the latter is conserved in all CFPs, Glu 210 is
variable in Cld-like CFPs [17, 34].
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5.3 Mimicking the Active Site of Cld-like Proteins
The double mutants W146Y R173Q and R173Q E210A and the single mutant R173Q
of NdCld were designed to mimick Cld-like CFPs, especially LmCld, which exhibits
Tyr, Gln and Ala at the corresponding positions in its active site cavity. The struc-
ture of heterologously expressed LmCld was solved recently (Mlynek et al., unpub-
lished data), not showing any electron density for heme. It was suggested that a
tyrosine residue (Tyr 147, corresponding to Ile 137 in NdCld) in the active site cav-
ity might clash with a heme, preventing it to bind (Mlynek et al., unpublished data).
Furthermore, no chlorite dismutase activity could be detected for LmCld (Füreder et
al., unpublished data). Based on the highly active NdCld, the mutants of proposed
signature residues resembling the active site of LmCld or other CFPs in the same
cluster enable us to assess and quantify the enzymatic potency of LmCld for chlorite
degradation.
The single mutant R173Q has, as described in Section 5.1, a catalytic efficiency re-
duced by one order of magnitude compared to wild-type NdCld, which was consis-
tent throughout all mutations of the catalytic arginine. Its KM is increased by a factor
of two, the turnover rate reaches merely 5% of the wild-type rate. Both double mu-
tants exhibit significantly reduced catalytic efficiency, with KMkcat of the E210A R173Q
double mutant being two orders of magnitude lower than the wild-type enzyme and
is therefore catalytically the weakest mutant produced. Its KM is four times higher
than the wild-type and kcat is reduced at 2% of the wild-type turnover rate. The
W146Y R173Q mutant is only slighly more efficient with its KM also four times higher
compared to the wild-type and kcat at 10% of the wild-type turnover rate. Binding of
the heme was not influenced in the W146Y R173Q double mutant, with ASoretA280 = 1.8
compared to 2.1 in the wild-type. The heme binding ability of the R173Q E210A dou-
ble mutant seems to be more affected, though, with ASoretA280 = 0.9.
A triple mutant (W146Y R173Q E210A) was not generated, but the data from the two
double mutants suggest that its activity might be even further reduced.
Figure 28 shows the ”active site“ of LmCld and of the NdCld double mutant W146Y
R173Q superimposed with residues Trp 145, Tyr 146, Gln 173 and Glu/Ala 210 (Nd-
Cld numbering) displayed as stick models. The two subunits superimpose with an
r.m.s.d. of 1.44 Å over 214 cα-atoms (of 236). Except for Gln 173, which points straight
into the cavity in LmCld, the conformations of the individual side chains are very
similar. In LmCld and in the double mutant R173Q E210A, the proximal His-Glu-Lys
triad is interrupted, the glutamate being replaced by an alanine residue instead. As
discussed in Section 5.2, the single E210A mutant retains activity compared to other
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Figure 28: Stereoview of superposition of LmCld (green) and the W146Y R173Q mutant (yel-
low) structures with emphasized important residues (discussed in the text). Heme
could not be modeled for LmCld. Top number: NdCld numbering; bottom num-
ber: LmCld numbering of residues.
mutants, its catalytic efficiency being reduced by only one order of magnitude. There-
fore, the histidine does not solely depend on the H-bonding to the glutamate be ori-
ented correctly for coordination of iron. The E210A mutant of NdCld was not struc-
turally investigated, but the wild-type and the other mutant structures suggest that
Leu 205 contributes to restriction of the conformational freedom of His 160 through
hydrophobic interaction.
The proximal histidine in LmCld is in agreement with this; it is still be positioned
adequately for coordination of an iron. His 174 in LmCld is as well stabilized by
hydrophobic interactions from Met 219, which corresponds to Leu 205 of NdCld. Ser
225 in LmCld (Phe 211 in NdCld) is in hydrogen bonding distance (3.5 Å) to His 174.
Therefore Ser 225 might substitute partially the missing glutamate residue of the Lys-
Glu-His triad in stabilization of His 174, despite not being able no accept a second
hydrogen bond from Lys 141. This is supported by the slight tilt of His 174 in the
direction of Ser 225. Figure 29 displays a detailed view of this hydrogen bonding
network.
The aforementioned Tyr 147 was suggested to clash with a in silico modeled heme
molecule in the ”active site“ of LmCld (Mlynek et al., unpublished data, Figure 28).
Whether mutating this residue to a canonical Ile would enable LmCld to bind heme
was not investigated until now, but might be an option in the future.
69
5 Discussion
Figure 29: Stereoview of superposition of LmCld (green) and the W146Y R173Q mutant (yel-
low) structures. NdCld heme is displayed in gray. Ser 225 of LmCld possibly
hydrogen bonds to Nδ of His 174 via its hydroxyl group and therefore partly sub-
stitutes for the missing Glu 210. The Ser - His interaction is weaker due to the
longer distance of 3.5 Å.
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5.4 Exchanging Iron to Cobalt Leads to Decreased Substrate
Binding
Cobalt can be coordinated in a similar way as iron in heme proteins, namely in a
quadratic-bipyramidal way, as e.g. in cobalamins such as vitamin B12. There, the
central cobalt atom is coordinated by four nitrogens of a corrin ring equatorially and
axially by one dimethylbenzimidazole group [21]. As in heme proteins like chlorite
dismutase, the sixth coordination site is variable and can involve a substrate. Though
iron and cobalt have similar properties the substantially increased KM, which is ap-
prox. 13 times higher than in the wild-type and in the high µM-range in the cobalt
variant indicates that cobalt is not able to be coordinated by the substrate ClO−2 as the
axial ligand and substrate binding to the heme is not favoured. As soon as the sub-
strate is bound, processing occurs at approx. 25% of the wild-type turnover rate. Ex-
changing the metals was an approach to generate an inactive form of NdCld, which
would enable to trap a substrate-bound or intermediate state of the reaction. With
an highly increases KM and substrate being still processed, the cobalt variant is the
inverse of what was aimed for.
5.5 The Structure of Apo-NdCld
Although being a pentamer in solution, apo-NdCld forms hexamers in the crystal
structure. This observation is in agreement with the chlorite dismutase from Azospira
oryzae, which was found by de Geus et al. [12] to form heme-loaded hexamers in the
crystal. Native mass spectrometry revealed this also to be a crystallographic artifact,
AoCld being a pentamer in solution. A possible mechanism would be the existence of
both penta- and hexameric molecules in solution, with only the hexamers crystalliz-
ing, but the static light scattering data do not support this. The determined molecular
mass corresponds to 5.0 monomers of apo-NdCld. Analysis of the hexameric struc-
ture by PISA is in agreement with this data, suggesting that a hexamer might not be
stable in solution due to the lack of specific interactions between the single subunits.
This implies that the protein has to rearrange from the pentameric solution struc-
ture to the hexameric crystal structure upon crystallization. The structural changes in
the active site (see Figure 25) could destabilize the contacts between the single sub-
units, with e.g. the pair of tryptophanes being closely positioned to the subunit in-
terface. These slight conformational changes might favour complete rearrangement
of the molecules during crystallization. Apo-NdCld crystallizes in approx. 50% of
conditions of the PACT I+II screen, but only two of these conditions were used for
diffraction experiments, with the protein being a hexamer in both. Different crystal
forms and packing could well be present in other crystallization conditions, which
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were not tested and optimized for. There, the protein could be present as a pentamer.
The contribution of the heme to the stability of NdCld was also experimentally deter-
mined by DSC (Gysel and Hofbauer, unpublished data), with the TM of apo-NdCld
being 30◦C lower than the very heat-stable holo-NdCld, which has a TM of 90◦C.
This confirms the contribution of bound heme to the overall stability of the protein.
5.6 Mixed Nature of the NwCld Dimer Interface
We determined the molecular mass of NwCld in solution under increasing ionic
strength by analytical SEC, with the protein remaining clearly a dimer even at high
ionic strengths. This indicates that hydrophobic interactions play a more important
role in the dimer interface of NwCld as previously assumed and suggested by PISA
[34]. Only 17% of the interface surface is hydrophobic in nature, while 16 hydro-
gen bonds and 4 salt bridges were found by PISA to connect the subunits. This low
amount of hydrophobic side chains seems to be sufficient to keep the dimer stable
at high ionic strengths up to 2 M NaCl [34]. The dimer interface consists thus of
a constructive interdependency of both hydrophobic and electrostatic interactions.
Additionally, the dimeric nature of NwCld in solution was experimentally confirmed
by a Static Light Scattering experiment.
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6 Conclusions
The large diversity of the chlorite dismutase family proteins still presents several chal-
lenges.
This thesis confirms the importance of several residues in the active site of the en-
zyme for the chlorite degradation mechanism and presents an intermediate step from
where further structural and biochemical studies to elucidate the mechanism of chlo-
rite bioremediation could emerge. The next stage in elucidating details of the reaction
mechanism will be reached by redox potential experiments on the mutants designed
and produced in this study. The resulting data about the heme environment could
lead to further insights to the contribution of the various side chains. Furthermore,
X-ray structures of several NdCld point mutants are provided, which demonstrate
that mutating the active site residues do not change the overall protein fold. This
strengthens the hypothesis, that all CFPs share a common, ancient fold, but only a
small subset of them is involved in chlorite degradation and can be identified using
the signature residues postulated by Mlynek et al. [34]. This study contributed to
the crystal structures gallery of apo-NdCld and of NwCld. While the latter is a func-
tional, truncated dimer with a novel subunit interface, but nevertheless shares the
core chlorite dismutase structure, the former is an artificial hexamer in the crystal,
but a pentamer in solution. This supports that the chlorite dismutase reaction is not
depending on the oligomeric state of the protein, but rather on the single subunits.
Based on this, DSC and CD experiments will be carried out which assay the thermal
stability of NwCld, holo-NdCld and apo-NdCld, shedding light on contributions of
oligomeric state and heme binding on the stability of the fold and the quarternary
structure (Gysel and Hofbauer, unpublished data).
Substrates and activities of the Cld-like CFPs still remain an unsolved mystery, yet
their importance has been shown in the case of Listeria monocytogenes, where LmCld
is essential for the viability of this organism. The studies on the NdCld mutants which
resemble the Cld-like protein of L. monocytogenes indicate that LmCld is not involved
in chlorite degradation. Whether Cld-like proteins possess the same essential func-
tion in other organisms as in L. monocytogenes, remains also yet unknown. Unveiling
this still mysterious function could not only provide us with insights about an ancient
unique protein family, widely distributed in bacterial and archaeal phylae, but also
constitute a valuable potential drug-target.
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friendly lab. ULRICH helped with the SLS experiments. Thanks also to MADS. And
of course to all the other members of the Djinovic group, whom I did not mention.
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THOMAS, MORKOS, CHRISTIAN, MATTHIAS and ROBERT. Thank you! For much pro-
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Vielen Dank! Mange tak! Tack så mycket! Thanks a lot! Deˇkuji!
– Kira
Somewhere between Jylland and Sjælland, Denmark, Aug 28th , 2011. So long, and thanks for all the fish! Vi ses!
2Don’t try this at home, kids...
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